284 results on '"Temporelli P"'
Search Results
2. Desde el corazón de la Iglesia: Mártires cristianas de ayer Mujeres no olvidadas
- Author
-
María Clara Temporelli
- Subjects
Mujeres mártires ,cuerpo ,Cuerpo ,Torturas ,Violencia Sexual ,Religion (General) ,BL1-50 - Abstract
En este escrito haremos memoria de las mártires dejándonos iluminar por estas mujeres de comienzos del cristianismo, su situación, su contexto socio-cultural, eclesial, su realidad de mujeres. El tratamiento dispensado al cuerpo femenino en los relatos de martirio, entre los siglos I al IV d. C., permite presentar a las mártires como la subversión de la debilidad y fragilidad de su sexo (infirmitas sexus), y la violencia deliberadamente experimentada por ellas, como vía por transgredir el orden social. Trataremos de realizar una aproximación al sentido del martirio cristiano. Analizaremos el martirio de algunas santas, tanto desde el punto de vista formal como observando su significado y fundamentación en las fuentes literarias. En este estudio confirmamos el puente existente entre el martirio de Jesucristo, los mártires y las mártires, ellos y ellas forman una nueva genealogía, son descendientes de Jesús y martirizados como Él; los une una misma identidad de fe, de fortaleza e integridad para entregar la vida y recordarnos que detrás de todo martirio hay un asesinato.
- Published
- 2024
- Full Text
- View/download PDF
3. Trends in sudden cardiac death mortality in Italy, 2013–2019
- Author
-
Zuin, Marco, Rigatelli, Gianluca, Cavedon, Stefano, Temporelli, Pier Luigi, and Bilato, Claudio
- Published
- 2024
- Full Text
- View/download PDF
4. Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem
- Author
-
Abrignani, Maurizio Giuseppe, Gronda, Edoardo, Marini, Marco, Gori, Mauro, Iacoviello, Massimo, Temporelli, Pier Luigi, Benvenuto, Manuela, Binaghi, Giulio, Cesaro, Arturo, Maloberti, Alessandro, Tinti, Maria Denitza, Riccio, Carmine, Colivicchi, Furio, Grimaldi, Massimo, Gabrielli, Domenico, and Oliva, Fabrizio
- Published
- 2024
- Full Text
- View/download PDF
5. Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional‐Based Italian Database
- Author
-
Valérie Tikhonoff, Edoardo Casiglia, Agostino Virdis, Guido Grassi, Fabio Angeli, Marcello Arca, Carlo M. Barbagallo, Michele Bombelli, Federica Cappelli, Rosario Cianci, Arrigo F. G. Cicero, Massimo Cirillo, Pietro Cirillo, Raffaella Dell'oro, Lanfranco D'elia, Giovambattista Desideri, Claudio Ferri, Ferruccio Galletti, Loreto Gesualdo, Cristina Giannattasio, Guido Iaccarino, Francesca Mallamaci, Alessandro Maloberti, Stefano Masi, Maria Masulli, Alberto Mazza, Alessandro Mengozzi, Maria Lorenza Muiesan, Pietro Nazzaro, Paolo Palatini, Gianfranco Parati, Roberto Pontremoli, Fosca Quarti‐Trevano, Marcello Rattazzi, Gianpaolo Reboldi, Giulia Rivasi, Elisa Russo, Massimo Salvetti, Pier Luigi Temporelli, Giuliano Tocci, Andrea Ungar, Paolo Verdecchia, Francesca Viazzi, Massimo Volpe, and Claudio Borghi
- Subjects
cardiovascular disease ,cutoff value ,hypertriglyceridemia ,mortality ,triglyceride ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background Despite longstanding epidemiologic data on the association between increased serum triglycerides and cardiovascular events, the exact level at which risk begins to rise is unclear. The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension has conceived a protocol aimed at searching for the prognostic cutoff value of triglycerides in predicting cardiovascular events in a large regional‐based Italian cohort. Methods and Results Among 14 189 subjects aged 18 to 95 years followed‐up for 11.2 (5.3–13.2) years, the prognostic cutoff value of triglycerides, able to discriminate combined cardiovascular events, was identified by means of receiver operating characteristic curve. The conventional (150 mg/dL) and the prognostic cutoff values of triglycerides were used as independent predictors in separate multivariable Cox regression models adjusted for age, sex, body mass index, total and high‐density lipoprotein cholesterol, serum uric acid, arterial hypertension, diabetes, chronic renal disease, smoking habit, and use of antihypertensive and lipid‐lowering drugs. During 139 375 person‐years of follow‐up, 1601 participants experienced cardiovascular events. Receiver operating characteristic curve showed that 89 mg/dL (95% CI, 75.8–103.3, sensitivity 76.6, specificity 34.1, P
- Published
- 2024
- Full Text
- View/download PDF
6. Multidistrict atherosclerotic disease: epidemiological and clinical framework
- Author
-
Di Fusco, S, Abrignani, M, Amico, A, Luca, F, Mureddu, G, Ceravolo, R, Temporelli, P, Acerbo, V, Altamura, V, Baccino, D, Binaghi, G, Bugani, G, Cesaro, A, Ciccirillo, F, Cocozza, S, D'Errigo, P, Di Martino, M, Di Nora, C, Fileti, L, Lopriore, V, Maloberti, A, Monitillo, F, Gulizia, M, Grimaldi, M, Gabrielli, D, Oliva, F, Colivicchi, F, Di Fusco S. A., Abrignani M. G., Amico A. F., Luca F., Mureddu G. F., Ceravolo R., Temporelli P. L., Acerbo V., Altamura V., Baccino D., Binaghi G., Bugani G., Cesaro A., Ciccirillo F., Cocozza S., D'Errigo P., Di Martino M., Di Nora C., Fileti L., Lopriore V., Maloberti A., Monitillo F., Gulizia M. M., Grimaldi M., Gabrielli D., Oliva F., Colivicchi F., Di Fusco, S, Abrignani, M, Amico, A, Luca, F, Mureddu, G, Ceravolo, R, Temporelli, P, Acerbo, V, Altamura, V, Baccino, D, Binaghi, G, Bugani, G, Cesaro, A, Ciccirillo, F, Cocozza, S, D'Errigo, P, Di Martino, M, Di Nora, C, Fileti, L, Lopriore, V, Maloberti, A, Monitillo, F, Gulizia, M, Grimaldi, M, Gabrielli, D, Oliva, F, Colivicchi, F, Di Fusco S. A., Abrignani M. G., Amico A. F., Luca F., Mureddu G. F., Ceravolo R., Temporelli P. L., Acerbo V., Altamura V., Baccino D., Binaghi G., Bugani G., Cesaro A., Ciccirillo F., Cocozza S., D'Errigo P., Di Martino M., Di Nora C., Fileti L., Lopriore V., Maloberti A., Monitillo F., Gulizia M. M., Grimaldi M., Gabrielli D., Oliva F., and Colivicchi F.
- Abstract
Atherosclerosis is a systemic disease that can involve different arterial districts. Traditionally, the focus of cardiologists has been on the diagnosis and treatment of atherosclerotic coronary artery disease (CAD). However, atherosclerosis localization in other districts is increasingly common and is associated with an increased risk of CAD and, more generally, of adverse cardiovascular events. Although the term peripheral arterial disease (PAD) commonly refers to the localization of atherosclerotic disease in the arterial districts of the lower limbs, in this document, in accordance with the European Society of Cardiology guidelines, the term PAD will be used for all the locations of atherosclerotic disease excluding coronary and aortic ones. The aim of this review is to report updated data on PAD epidemiology, with particular attention to the prevalence and its prognostic impact on patients with CAD. Furthermore, the key points for an appropriate diagnostic framework and a correct pharmacological therapeutic approach are summarized, while surgical/interventional treatment goes beyond the scope of this review.
- Published
- 2024
7. Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem
- Author
-
Abrignani, M, Gronda, E, Marini, M, Gori, M, Iacoviello, M, Temporelli, P, Benvenuto, M, Binaghi, G, Cesaro, A, Maloberti, A, Tinti, M, Riccio, C, Colivicchi, F, Grimaldi, M, Gabrielli, D, Oliva, F, Abrignani M. G., Gronda E., Marini M., Gori M., Iacoviello M., Temporelli P. L., Benvenuto M., Binaghi G., Cesaro A., Maloberti A., Tinti M. D., Riccio C., Colivicchi F., Grimaldi M., Gabrielli D., Oliva F., Abrignani, M, Gronda, E, Marini, M, Gori, M, Iacoviello, M, Temporelli, P, Benvenuto, M, Binaghi, G, Cesaro, A, Maloberti, A, Tinti, M, Riccio, C, Colivicchi, F, Grimaldi, M, Gabrielli, D, Oliva, F, Abrignani M. G., Gronda E., Marini M., Gori M., Iacoviello M., Temporelli P. L., Benvenuto M., Binaghi G., Cesaro A., Maloberti A., Tinti M. D., Riccio C., Colivicchi F., Grimaldi M., Gabrielli D., and Oliva F.
- Abstract
Hyperkalaemia is one of the most common electrolyte disorders in patients with cardiovascular disease (CVD). The true burden of hyperkalaemia in the real-world setting can be difficult to assess, but in population-based cohort studies up to 4 in 10 patients developed hyperkalaemia. In addition to drugs interfering with potassium metabolism and food intake, several conditions can cause or worsen hyperkalaemia, such as advanced age, diabetes, and chronic kidney disease. Mortality, cardiovascular morbidity, and hospitalisation are higher in patients with hyperkalaemia. Hyperkalaemia represents a major contraindication or a withholding cause for disease-modifying therapies like renin–angiotensin–aldosterone inhibitors (RAASi), mainly mineralocorticoid receptor antagonists. Hyperkalaemia can be also classified as acute and chronic, according to the onset. Acute hyperkalaemia is often a life-threatening emergency requiring immediate treatment to avoid lethal arrhythmias. Therapy goal is cell membrane stabilisation by calcium administration, cellular intake, shift of extracellular potassium to the intracellular space (insulin, beta-adrenergic agents, sodium bicarbonate), and increased elimination with diuretics or dialysis. Chronic hyperkalaemia was often managed with dietary counselling to prevent potassium-rich food intake and tapering of potassium-increasing drugs, mostly RAASi. Sodium polystyrene sulphonate, a potassium binder, was the only therapeutic option. Recently, new drugs such as patiromer and sodium zirconium cyclosilicate give new opportunities for the treatment of hyperkalaemia, as they proved to be safe, well tolerated, and effective. Aim of this review is to describe the burden of hyperkalaemia in cardiovascular patients, its direct and indirect effects, and the therapeutic options now available in the acute and chronic setting.
- Published
- 2024
8. Heart Failure with Preserved Ejection Fraction: How to Deal with This Chameleon
- Author
-
Luca, F, Oliva, F, Abrignani, M, Di Fusco, S, Gori, M, Giubilato, S, Ceravolo, R, Temporelli, P, Cornara, S, Rao, C, Caretta, G, Pozzi, A, Binaghi, G, Maloberti, A, Di Nora, C, Di Matteo, I, Pilleri, A, Gelsomino, S, Riccio, C, Grimaldi, M, Colivicchi, F, Gulizia, M, Luca F., Oliva F., Abrignani M. G., Di Fusco S. A., Gori M., Giubilato S., Ceravolo R., Temporelli P. L., Cornara S., Rao C. M., Caretta G., Pozzi A., Binaghi G., Maloberti A., Di Nora C., Di Matteo I., Pilleri A., Gelsomino S., Riccio C., Grimaldi M., Colivicchi F., Gulizia M. M., Luca, F, Oliva, F, Abrignani, M, Di Fusco, S, Gori, M, Giubilato, S, Ceravolo, R, Temporelli, P, Cornara, S, Rao, C, Caretta, G, Pozzi, A, Binaghi, G, Maloberti, A, Di Nora, C, Di Matteo, I, Pilleri, A, Gelsomino, S, Riccio, C, Grimaldi, M, Colivicchi, F, Gulizia, M, Luca F., Oliva F., Abrignani M. G., Di Fusco S. A., Gori M., Giubilato S., Ceravolo R., Temporelli P. L., Cornara S., Rao C. M., Caretta G., Pozzi A., Binaghi G., Maloberti A., Di Nora C., Di Matteo I., Pilleri A., Gelsomino S., Riccio C., Grimaldi M., Colivicchi F., and Gulizia M. M.
- Abstract
Heart failure with preserved ejection fraction (HFpEF) is characterized by a notable heterogeneity in both phenotypic and pathophysiological features, with a growing incidence due to the increase in median age and comorbidities such as obesity, arterial hypertension, and cardiometabolic disease. In recent decades, the development of new pharmacological and non-pharmacological options has significantly impacted outcomes, improving clinical status and reducing mortality. Moreover, a more personalized and accurate therapeutic management has been demonstrated to enhance the quality of life, diminish hospitalizations, and improve overall survival. Therefore, assessing the peculiarities of patients with HFpEF is crucial in order to obtain a better understanding of this disorder. Importantly, comorbidities have been shown to influence symptoms and prognosis, and, consequently, they should be carefully addressed. In this sense, it is mandatory to join forces with a multidisciplinary team in order to achieve high-quality care. However, HFpEF remains largely under-recognized and under-treated in clinical practice, and the diagnostic and therapeutic management of these patients remains challenging. The aim of this paper is to articulate a pragmatic approach for patients with HFpEF focusing on the etiology, diagnosis, and treatment of HFpEF.
- Published
- 2024
9. Lipoproteina(a): associazione con la malattia aterosclerotica e valvolare e terapie emergenti
- Author
-
Abrignani, M, Maloberti, A, Fusco, S, Luca, F, Cesaro, A, Acerbo, V, Fabbri, S, Matteo, I, Amico, A, Temporelli, P, Riccio, C, Colivicchi, F, Grimaldi, M, Gabrielli, D, Oliva, F, Abrignani M. G., Maloberti A., Fusco S. A. D., Luca F., Cesaro A., Acerbo V., Fabbri S., Matteo I. D., Amico A. F., Temporelli P. L., Riccio C., Colivicchi F., Grimaldi M., Gabrielli D., Oliva F., Abrignani, M, Maloberti, A, Fusco, S, Luca, F, Cesaro, A, Acerbo, V, Fabbri, S, Matteo, I, Amico, A, Temporelli, P, Riccio, C, Colivicchi, F, Grimaldi, M, Gabrielli, D, Oliva, F, Abrignani M. G., Maloberti A., Fusco S. A. D., Luca F., Cesaro A., Acerbo V., Fabbri S., Matteo I. D., Amico A. F., Temporelli P. L., Riccio C., Colivicchi F., Grimaldi M., Gabrielli D., and Oliva F.
- Abstract
Lipoprotein(a) [Lp(a)] is a well-established cardiovascular risk factor, whose relationship with atherosclerotic disease has been confirmed by epidemiological, genome-wide association, Mendelian randomization, and meta-analysis studies. This association is determined by its pro-atherogenic, pro-thrombotic and pro-inflammatory properties. Lp(a) is the most common monogenic risk factor for atherosclerosis, with a prevalence of about 1 in 5 people. Recently, its etiopathogenetic relationship with calcific and degenerative valvular heart diseases, particularly with aortic and mitral stenosis, has been suspected. It has not yet been demonstrated whether its reduction translates into a lower risk of cardiovascular events. Up to now, Lp(a) has been considered a non-modifiable risk factor, as current lipid-lowering drugs have limited effects on its levels. New specific lipid-lowering therapies with high efficacy in reducing circulating Lp(a) levels are being investigated in randomized trials; however, the effects of this reduction on cardiovascular outcomes are still being studied.
- Published
- 2024
10. Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional‐Based Italian Database
- Author
-
Tikhonoff, V, Casiglia, E, Virdis, A, Grassi, G, Angeli, F, Arca, M, Barbagallo, C, Bombelli, M, Cappelli, F, Cianci, R, Cicero, A, Cirillo, M, Cirillo, P, Dell'Oro, R, D'Elia, L, Desideri, G, Ferri, C, Galletti, F, Gesualdo, L, Giannattasio, C, Iaccarino, G, Mallamaci, F, Maloberti, A, Masi, S, Masulli, M, Mazza, A, Mengozzi, A, Muiesan, M, Nazzaro, P, Palatini, P, Parati, G, Pontremoli, R, Quarti-Trevano, F, Rattazzi, M, Reboldi, G, Rivasi, G, Russo, E, Salvetti, M, Temporelli, P, Tocci, G, Ungar, A, Verdecchia, P, Viazzi, F, Volpe, M, Borghi, C, Tikhonoff V., Casiglia E., Virdis A., Grassi G., Angeli F., Arca M., Barbagallo C. M., Bombelli M., Cappelli F., Cianci R., Cicero A. F. G., Cirillo M., Cirillo P., Dell'oro R., D'elia L., Desideri G., Ferri C., Galletti F., Gesualdo L., Giannattasio C., Iaccarino G., Mallamaci F., Maloberti A., Masi S., Masulli M., Mazza A., Mengozzi A., Muiesan M. L., Nazzaro P., Palatini P., Parati G., Pontremoli R., Quarti-Trevano F., Rattazzi M., Reboldi G., Rivasi G., Russo E., Salvetti M., Temporelli P. L., Tocci G., Ungar A., Verdecchia P., Viazzi F., Volpe M., Borghi C., Tikhonoff, V, Casiglia, E, Virdis, A, Grassi, G, Angeli, F, Arca, M, Barbagallo, C, Bombelli, M, Cappelli, F, Cianci, R, Cicero, A, Cirillo, M, Cirillo, P, Dell'Oro, R, D'Elia, L, Desideri, G, Ferri, C, Galletti, F, Gesualdo, L, Giannattasio, C, Iaccarino, G, Mallamaci, F, Maloberti, A, Masi, S, Masulli, M, Mazza, A, Mengozzi, A, Muiesan, M, Nazzaro, P, Palatini, P, Parati, G, Pontremoli, R, Quarti-Trevano, F, Rattazzi, M, Reboldi, G, Rivasi, G, Russo, E, Salvetti, M, Temporelli, P, Tocci, G, Ungar, A, Verdecchia, P, Viazzi, F, Volpe, M, Borghi, C, Tikhonoff V., Casiglia E., Virdis A., Grassi G., Angeli F., Arca M., Barbagallo C. M., Bombelli M., Cappelli F., Cianci R., Cicero A. F. G., Cirillo M., Cirillo P., Dell'oro R., D'elia L., Desideri G., Ferri C., Galletti F., Gesualdo L., Giannattasio C., Iaccarino G., Mallamaci F., Maloberti A., Masi S., Masulli M., Mazza A., Mengozzi A., Muiesan M. L., Nazzaro P., Palatini P., Parati G., Pontremoli R., Quarti-Trevano F., Rattazzi M., Reboldi G., Rivasi G., Russo E., Salvetti M., Temporelli P. L., Tocci G., Ungar A., Verdecchia P., Viazzi F., Volpe M., and Borghi C.
- Abstract
BACKGROUND: Despite longstanding epidemiologic data on the association between increased serum triglycerides and cardiovascular events, the exact level at which risk begins to rise is unclear. The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension has conceived a protocol aimed at searching for the prognostic cutoff value of triglycerides in predicting cardiovascular events in a large regional-based Italian cohort. METHODS AND RESULTS: Among 14 189 subjects aged 18 to 95 years followed-up for 11.2 (5.3–13.2) years, the prognostic cutoff value of triglycerides, able to discriminate combined cardiovascular events, was identified by means of receiver operating characteristic curve. The conventional (150 mg/dL) and the prognostic cutoff values of triglycerides were used as independent predictors in separate multivariable Cox regression models adjusted for age, sex, body mass index, total and high-density lipoprotein cholesterol, serum uric acid, arterial hypertension, diabetes, chronic renal disease, smoking habit, and use of an-tihypertensive and lipid-lowering drugs. During 139 375 person-years of follow-up, 1601 participants experienced cardiovascular events. Receiver operating characteristic curve showed that 89 mg/dL (95% CI, 75.8–103.3, sensitivity 76.6, specificity 34.1, P<0.0001) was the prognostic cutoff value for cardiovascular events. Both cutoff values of triglycerides, the conventional and the newly identified, were accepted as multivariate predictors in separate Cox analyses, the hazard ratios being 1.211 (95% CI, 1.063–1.378, P=0.004) and 1.150 (95% CI, 1.021–1.295, P=0.02), respectively. CONCLUSIONS: Lower (89 mg/dL) than conventional (150 mg/dL) prognostic cutoff value of triglycerides for cardiovascular events does exist and is associated with increased cardiovascular risk in an Italian cohort.
- Published
- 2024
11. Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction
- Author
-
Caterina Maffeis, Andrea Rossi, Lorenzo Cannata, Camilla Zocco, Evgeny Belyavskiy, Aravind Kumar Radhakrishnan, Anna Feuerstein, Daniel Armando Morris, Elisabeth Pieske‐Kraigher, Burkert Pieske, Frank Edelmann, and Pier Luigi Temporelli
- Subjects
Left atrial strain ,Cardiopulmonary exercise test ,Exercise capacity ,Heart failure ,Ejection fraction ,Prognosis ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims We hypothesized that left atrial (LA) remodelling and function are associated with poor exercise capacity as prognostic marker in chronic heart failure (CHF) across a broad range of left ventricular ejection fraction (LVEF). Methods and results One hundred seventy‐one patients with CHF were analysed [age 65 ± 11 years, 136 males (80%); 86 heart failure with reduced ejection fraction (HFrEF), 27 heart failure with mid‐range ejection fraction (HFmrEF), 58 heart failure with preserved ejection fraction (HFpEF)]. All patients underwent echocardiography and maximal cardiopulmonary exercise testing and were classified according to a prognostic cut‐off of peak VO2 (pVO2; 14 mL/kg/min). Seventy‐seven (45%) patients reached pVO2
- Published
- 2022
- Full Text
- View/download PDF
12. LCA and C-LCC Indicator as Tools for Sodium-Ion Batteries’ Eco-Design
- Author
-
Maria Leonor Carvalho, Maria Anna Cusenza, Giulio Mela, Andrea Temporelli, Irene Quinzeni, and Pierpaolo Girardi
- Subjects
sodium-ion batteries ,LCA ,environmental impact ,resource use ,scarcity ,C-LCC ,Technology - Abstract
Sodium-ion batteries are considered promising alternatives to lithium-ion technology; however, the diffusion on a commercial scale is hindered by the struggle to identify materials with high electrochemical performances. Studies available in the literature are mainly focused on electrochemical performance and neglect aspects related to the environmental sustainability. In fact, the current state-of-the-art (presented in this study) shows that life cycle assessment (LCA) studies related to the production processes of electrode materials for Na-ion batteries are still very limited. The LCA methodology applied during the development of a technology phase can constitute a valid support for an eco-oriented design and, therefore, to the choice of solutions characterized by a lower environmental impact with the same electrochemical performance. In this context, a life cycle-based environmental–economic assessment was performed to evaluate the environmental impacts of the production process of cathode and anode materials for sodium-ion batteries. The study is focused on the cathodic active material Na0.66MnO2, considering two synthesis paths, and the anodic material consisting of tin (Sn) and Sn-carbon nanofiber (Sn-Cn) active material, binder, and other additives. Results illustrate the environmental performance of the different materials and constitute a useful input for their selection within an eco-design view.
- Published
- 2023
- Full Text
- View/download PDF
13. Estilos de vida, factores de riesgo y salud autopercibida de la población argentina
- Author
-
Pablo Daniel Monterubbianesi and Karina Luján Temporelli
- Subjects
Status de salud ,función de producción de salud ,factores de riesgo ,estilos de vida ,Economics as a science ,HB71-74 - Abstract
Al aplicar regresiones logísticas con datos de las cuatro Encuestas Nacionales de Factores de Riesgo (enfr) de Argentina, se estudió la relación entre el status de salud individual y sus determinantes, utilizando como marco teórico la función de producción de salud. Se hace especial hincapié en los estilos de vida por ser los que mayor influencia tienen sobre esta dimensión. El análisis de la evolución temporal muestra un incremento tanto en la obesidad como en el consumo de alcohol, poniendo de manifiesto la necesidad de intensificar estrategias públicas que incentiven estilos de vida menos riesgosos a fin de mejorar la salud de la población.
- Published
- 2022
- Full Text
- View/download PDF
14. Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI‐HF trial
- Author
-
Giovanni Targher, Gianluigi Lunardi, Alessandro Mantovani, Jennifer Meessen, Stefano Bonapace, Pier Luigi Temporelli, Enrico Nicolis, Deborah Novelli, Antonio Conti, Luigi Tavazzi, Aldo Pietro Maggioni, and Roberto Latini
- Subjects
Ceramides ,Heart failure ,Cardiovascular mortality ,Risk factors ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims Ceramides exert several biological activities that may contribute to the pathophysiology of cardiovascular disease and heart failure (HF). The association between plasma levels of distinct ceramides (that have been previously associated with increased cardiovascular risk) and cardiovascular mortality in patients with chronic HF has received little attention. Methods and results In a post hoc ancillary analysis of the Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure (GISSI‐HF; NCT00336336) trial, we randomly selected a sample of 200 ambulatory patients with chronic HF who died due to cardiovascular causes and 200 patients who were alive at the end of the trial (after a median follow‐up period of 3.9 years). We measured baseline plasma concentrations of six previously identified high‐risk ceramide species [Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/20:0), Cer(d18:1/22:0), Cer(d18:1/24:0), and Cer(d18:1/24:1) and their individual plasma ratios with Cer(d18:1/24:0)]. Patients who died due to cardiovascular causes had significantly (P
- Published
- 2020
- Full Text
- View/download PDF
15. Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study
- Author
-
Leonardo De Luca, Pier Luigi Temporelli, Furio Colivicchi, Lucio Gonzini, Maria Luisa Fasano, Massimo Pantaleoni, Gabriella Greco, Fabrizio Oliva, Domenico Gabrielli, and Michele Massimo Gulizia
- Subjects
hypercholesterolemia ,LDL-C ,management ,treatment ,statin ,chronic coronary syndrome ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundSeveral studies have reported that the combination of high TG and low HDL-C, as simplified by the TG/HDL-C ratio, was a predictor of cardiovascular disease independent of LDL-C level. Nevertheless, poor data are available on the predictive role of TG/HDL-C ratio in very high risk (VHR) patients with chronic coronary syndromes (CCS).MethodsUsing the data from the STable Coronary Artery Diseases RegisTry (START) study, an Italian nationwide registry, we assessed the association between the TG/HDL-C ratio and baseline clinical characteristics, pharmacological treatment, and major adverse cardio-cerebrovascular events (MACCE) at 1 year in a large cohort of CCS patients at VHR.ResultsVHR patients with both TG and HDL-C levels available were grouped in tertiles of TG/HDL-C ratio: low (TG/HDL-C ratio 3.3, n = 1,028). At 1 year from enrolment, 232 (7.6%) patients presented a MACCE, with a higher incidence in the higher tertile, even though not statistically significant (6.0, 8.2, and 8.4% in the low, middle and high tertile, respectively; p = 0.08). At multivariable analysis, the TG/HDL-C ratio in tertiles did not result an independent predictor of the MACCE (p = 0.29) at 1-year follow-up (HR: 1.30; 95% CI: 0.93–1.82; p = 0.12 middle vs. lower tertile, and HR: 1.22; 95% CI: 0.87–1.72; p = 0.25 higher vs. lower).ConclusionsIn the present large, nationwide cohort of CCS patients at VHR a high TG/HD ratio did not emerge as independent predictor of MACCE at 1 year. Further studies with a longer follow-up are needed to better define the prognostic role of TG/HDL ratio in CCS.
- Published
- 2022
- Full Text
- View/download PDF
16. The Key Role of a Psychoactive Substance Use History in Comprehensive Cardiovascular Risk Assessment, Diagnosis, Treatment, and Prevention
- Author
-
Ciccirillo, F, Abrignani, M, Temporelli, P, Binaghi, G, Cappelletto, C, Lopriore, V, Cesaro, A, Maloberti, A, Cozzoli, D, Riccio, C, Caldarola, P, Oliva, F, Gabrielli, D, Colivicchi, F, Ciccirillo F., Abrignani M. G., Temporelli P. L., Binaghi G., Cappelletto C., Lopriore V., Cesaro A., Maloberti A., Cozzoli D., Riccio C., Caldarola P., Oliva F., Gabrielli D., Colivicchi F., Ciccirillo, F, Abrignani, M, Temporelli, P, Binaghi, G, Cappelletto, C, Lopriore, V, Cesaro, A, Maloberti, A, Cozzoli, D, Riccio, C, Caldarola, P, Oliva, F, Gabrielli, D, Colivicchi, F, Ciccirillo F., Abrignani M. G., Temporelli P. L., Binaghi G., Cappelletto C., Lopriore V., Cesaro A., Maloberti A., Cozzoli D., Riccio C., Caldarola P., Oliva F., Gabrielli D., and Colivicchi F.
- Abstract
Background: Psychoactive substances have toxic effects resulting different cardiovascular and non-cardiovascular organ damage. Through a variety of mechanisms, they can trigger the onset of various forms of cardiovascular disease: acute or chronic, transient or permanent, subclinical or symptomatic. Hence, a thorough knowledge of the patient's drug habits is essential for a more complete clinical-etiopathogenetic diagnosis and consequent therapeutic, preventive, and rehabilitative management. Summary: The prime reason for taking a psychoactive substance use history in the cardiovascular context is to identify those people who use substances (whether habitual or occasional users, symptomatic or not) and adequately assess their overall cardiovascular risk profile in terms of "user status"and type of substance(s) used. A psychoactive substance history could also alert the physician to suspect, and eventually diagnose, cardiovascular disease related to the intake of psychoactive substances, so optimizing the medical management of users. This anamnesis could finally assess the likelihood of patients persisting in the habit as a user or relapse, while maintaining high their cardiovascular risk profile. Taking such a history should be mandatory when a causal connection is suspected between intake of psychoactive substances and the observed symptoms or pathology, regardless of whether the individual is a declared user or not. Key Messages: The purpose of this article was to provide practical information on when, how, and why to perform a psychoactive substance use history.
- Published
- 2023
17. Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
- Author
-
Luca, F, Oliva, F, Abrignani, M, Di Fusco, S, Parrini, I, Canale, M, Giubilato, S, Cornara, S, Nesti, M, Rao, C, Pozzi, A, Binaghi, G, Maloberti, A, Ceravolo, R, Bisceglia, I, Rossini, R, Temporelli, P, Amico, A, Calvanese, R, Gelsomino, S, Riccio, C, Grimaldi, M, Colivicchi, F, Gulizia, M, Luca F., Oliva F., Abrignani M. G., Di Fusco S. A., Parrini I., Canale M. L., Giubilato S., Cornara S., Nesti M., Rao C. M., Pozzi A., Binaghi G., Maloberti A., Ceravolo R., Bisceglia I., Rossini R., Temporelli P. L., Amico A. F., Calvanese R., Gelsomino S., Riccio C., Grimaldi M., Colivicchi F., Gulizia M. M., Luca, F, Oliva, F, Abrignani, M, Di Fusco, S, Parrini, I, Canale, M, Giubilato, S, Cornara, S, Nesti, M, Rao, C, Pozzi, A, Binaghi, G, Maloberti, A, Ceravolo, R, Bisceglia, I, Rossini, R, Temporelli, P, Amico, A, Calvanese, R, Gelsomino, S, Riccio, C, Grimaldi, M, Colivicchi, F, Gulizia, M, Luca F., Oliva F., Abrignani M. G., Di Fusco S. A., Parrini I., Canale M. L., Giubilato S., Cornara S., Nesti M., Rao C. M., Pozzi A., Binaghi G., Maloberti A., Ceravolo R., Bisceglia I., Rossini R., Temporelli P. L., Amico A. F., Calvanese R., Gelsomino S., Riccio C., Grimaldi M., Colivicchi F., and Gulizia M. M.
- Abstract
It is well established that direct oral anticoagulants (DOACs) are the cornerstone of anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and should be preferred over vitamin K antagonists (VKAs) since they are superior or non-inferior to VKAs in reducing thromboembolic risk and are associated with a lower risk of intracranial hemorrhage (IH). In addition, many factors, such as fewer pharmacokinetic interactions and less need for monitoring, contribute to the favor of this therapeutic strategy. Although DOACs represent a more suitable option, several issues should be considered in clinical practice, including drug–drug interactions (DDIs), switching to other antithrombotic therapies, preprocedural and postprocedural periods, and the use in patients with chronic renal and liver failure and in those with cancer. Furthermore, adherence to DOACs appears to remain suboptimal. This narrative review aims to provide a practical guide for DOAC prescription and address challenging scenarios.
- Published
- 2023
18. Substances of abuse and cardiovascular risk: Cannabinoids [Sostanze d’abuso e rischio cardiovascolare: i cannabinoidi]
- Author
-
Abrignani, M, Ciccirillo, F, Temporelli, P, Cesaro, A, Binaghi, G, Maloberti, A, Cappelletto, C, Oliva, F, Riccio, C, Caldarola, P, Gabrielli, D, Colivicchi, F, Abrignani M. G., Ciccirillo F., Temporelli P. L., Cesaro A., Binaghi G., Maloberti A., Cappelletto C., Oliva F., Riccio C., Caldarola P., Gabrielli D., Colivicchi F., Abrignani, M, Ciccirillo, F, Temporelli, P, Cesaro, A, Binaghi, G, Maloberti, A, Cappelletto, C, Oliva, F, Riccio, C, Caldarola, P, Gabrielli, D, Colivicchi, F, Abrignani M. G., Ciccirillo F., Temporelli P. L., Cesaro A., Binaghi G., Maloberti A., Cappelletto C., Oliva F., Riccio C., Caldarola P., Gabrielli D., and Colivicchi F.
- Abstract
Progressive legalization for medical conditions or recreational use has led to an increased use of cannabis and synthetic cannabinoids over the past years. Most consumers are young and healthy, without cardiovascular risk factors; however, this population is expected to include older individuals. Thus, concerns have arisen about safety and short- and long-term potential adverse effects, with special emphasis on vulnerable groups. Studies show that cannabis might be linked with thrombosis, inflammation, and atherosclerosis, and many reports have associated cannabis and synthetic cannabinoids use with serious adverse cardiovascular complications, including myocardial infarction, cardiomyopathy, arrhythmias, stroke, and cardiac arrest. A clearly defined causal role cannot be demonstrated, because of confounding variables. Physicians need to become aware of the possible spectrum of clinical presentations, not only for timely diagnosis and treatment, but also for effective counseling and prevention. In this review, we aim to provide a basic understanding of the physiological effects of cannabis, the role of the endocannabinoid system in cardiovascular disease, and the cardiovascular consequences of cannabis and synthetic cannabinoid use, including a comprehensive review of the studies and case reports that provide supportive evidence for cannabis as a trigger of adverse cardiovascular events according to the current literature.
- Published
- 2023
19. Brachial pulse pressure in acute heart failure. Results of the Heart Failure Registry
- Author
-
Stefano Bonapace, Andrea Rossi, Cécile Laroche, Maria G. Crespo‐Leiro, Massimo F. Piepoli, Andrew J.S. Coats, Ulf Dahlström, Filip Malek, Cezar Macarie, Pier Luigi Temporelli, Aldo P. Maggioni, Luigi Tavazzi, and the European Society of Cardiology Heart Failure Long‐Term Registry Investigators group
- Subjects
Pulse pressure ,Heart Failure ,Acute Heart Failure ,Prognosis ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims To investigate the still uncertain independent prognostic impact of pulse pressure (PP) in acute heart failure (HF), in particular across the left ventricular ejection fraction (EF) phenotypes, and the potential contribution of PP in outlining the individual phenotypes. Methods and results We prospectively evaluated 1‐year death and rehospitalization in 4314 patients admitted for acute HF grouped by EF and stratified by their PP level on admission. In HF with reduced ( 60 mmHg and SBP > 140 mmHg was associated to a preserved EF with a high performance value. No prognostic significance of PP was found in the HF with mid‐range EF subgroup. Conclusions In acute HFrEF, there is an almost linear inverse relation between mortality and PP, partly mediated by SBP. In HFpEF, a J‐shaped relationship between mortality and PP was present with a better prognosis at the nadir. A combination of PP > 60 mmHg with SBP > 140 mmHg may be clinically helpful as marker of a preserved left ventricular EF.
- Published
- 2019
- Full Text
- View/download PDF
20. Last Mile Logistics Life Cycle Assessment: A Comparative Analysis from Diesel Van to E-Cargo Bike
- Author
-
Andrea Temporelli, Paola Cristina Brambilla, Elisabetta Brivio, and Pierpaolo Girardi
- Subjects
e-logistics ,e-cargo bike ,last mile logistics ,urban logistics ,life cycle assessment ,environmental impacts ,Technology - Abstract
With the proliferation of e-commerce, the field of last-mile logistics has grown increasingly, highlighting the need to manage the environmental consequences of this phenomenon, especially to achieve decarbonization targets for cities and to improve citizens’ quality of life. Within this framework, the authors carried out a last-mile logistics life cycle assessment, to analyse and compare different logistics vehicle options performing the same service in an urban context: an electric four-wheel cargo bike, an electric van, a plug-in hybrid van, and a diesel van. The assessment shows that the e-cargo bike performs better for all the impact categories considered. The second-best option is the e-van, while the diesel van shows the worst environmental results. Focusing on decarbonization, the replacement of a diesel van with an electric one or with an e-cargo bike allows a reduction of 173 g CO2 eq/km and 250 g CO2 eq/km, respectively. Similar results are obtained for Photochemical Ozone Formation with associated emissions of 0.18, 0.31, 0.45 and 0.49 g NMVOC eq/km for the e-cargo bike, e-van, plug in hybrid van and diesel van, respectively. The only exceptions are Human Health impact categories, Acidification and Respiratory inorganics, for which the plug-in hybrid van performs worst, and Resource use, Mineral and Metals, for which the electric van performs worst.
- Published
- 2022
- Full Text
- View/download PDF
21. Association of Hypertriglyceridemia with All‐Cause Mortality and Atherosclerotic Cardiovascular Events in a Low‐Risk Italian Population: The TG‐REAL Retrospective Cohort Analysis
- Author
-
Marcello Arca, Chiara Veronesi, Laura D’Erasmo, Claudio Borghi, Furio Colivicchi, Gaetano Maria De Ferrari, Giovambattista Desideri, Roberto Pontremoli, Pier Luigi Temporelli, Valentina Perrone, and Luca Degli Esposti
- Subjects
all‐cause mortality ,atherosclerotic cardiovascular disease ,hypertriglyceridemia ,real‐world ,triglycerides ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background Evidence regarding the relationships among high plasma triglycerides (TG), all‐cause mortality, and atherosclerotic cardiovascular disease (ASCVD) events in low‐to‐moderate risk individuals is limited. The aim of this study was to determine whether the presence of high TG levels influences the risk of all‐cause mortality and ASCVD events in a population cohort followed in the real‐world clinical setting. Methods and Results A retrospective longitudinal cohort analysis using administrative databases of 3 Italian Local Health Units was performed. All individuals with at least one TG measurement between January 1, 2010 and December 31, 2015 were followed through December 2016. Outcome measures included incident ASCVD events and all‐cause mortality. Individuals with normal TG levels (500 mg/dL). 158 042 individuals (142 289 with normal, 15 558 with high, and 195 with very high TG) were considered. In the whole cohort, the overall incidence rates of ASCVD and all‐cause mortality were 7.2 and 17.1 per 1000 person‐years, respectively. After multivariate adjustment for potential confounders, individuals with high and very high TG showed a significantly increased risk of all‐cause mortality (hazard ratio [HR]=1.49 [95% confidence interval (CI) 1.36–1.63], P
- Published
- 2020
- Full Text
- View/download PDF
22. Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation
- Author
-
Rossi, A., Dini, F. L., Agricola, E., Faggiano, P., Benfari, G., Temporelli, P. L., Cucco, C., Scelsi, L., Vassanelli, C., and Ghio, S.
- Published
- 2018
- Full Text
- View/download PDF
23. Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries
- Author
-
Furio Colivicchi, Michele Massimo Gulizia, Marcello Arca, Pier Luigi Temporelli, Lucio Gonzini, Vanessa Venturelli, Nuccia Morici, Ciro Indolfi, Domenico Gabrielli, and Leonardo De Luca
- Subjects
Therapeutics. Pharmacology ,RM1-950 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Introduction. The current use of lipid lowering therapies and the eligibility for proprotein convertase subtilisin/kexin-9 (PCSK9) inhibitors of patients surviving a myocardial infarction (MI) is poorly known. Methods. Using the data from two contemporary, nationwide, prospective, real-world registries of patients with stable coronary artery disease, we sought to describe the lipid lowering therapies prescribed by cardiologists in patients with a prior MI and the resulting eligibility for PCSK9 inhibitors according to the European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) and the Italian regulatory agency (Agenzia Italiana del Farmaco; AIFA) criteria. The study cohort was stratified according to the following low-density lipoprotein cholesterol (LDL-C) levels at the time of enrolment:
- Published
- 2020
- Full Text
- View/download PDF
24. Referral from vascular surgery to cardiovascular rehabilitation and related outcomes in patients with peripheral arterial disease: the THINKPAD-RELOADED survey
- Author
-
Marco Ambrosetti, Pompilio Faggiano, Cesare Greco, Gian Francesco Mureddu, Pier Luigi Temporelli, and Roberto F.E. Pedretti
- Subjects
Peripheral arterial disease ,rehabilitation ,exercise ,referral ,Medicine - Abstract
The utilization of cardiovascular rehabilitation (CR) programmes in patients with Lower Extremity Peripheral Artery Disease (LEPAD) is generally poor, with limited evidence of current policies for referral. The aim of the study was to evaluate, within a cohesive network of CR and vascular surgery facilities with facilitated referral process, the clinical characteristic of LEPAD patients referred to CR and related outcomes, as compared to patients not referred. The present is an observational prospective study of consecutive patients recruited at vascular surgery facilities. Out of 329 patients observed, the average referral rate to CR was 34% (28% and 39% in patients with and without recent peripheral revascularization, p
- Published
- 2019
- Full Text
- View/download PDF
25. Similar predictive value of six-minute walking distance and B-type natriuretic peptide in heart failure with reduced to mid-range ejection fraction
- Author
-
Angela Beatrice Scardovi, Renata De Maria, Gian Giacomo Galeotti, Pompilio Faggiano, Luca Arcari, Stefano Ghio, Pier Luigi Temporelli, Andrea Rossi, Giovanna Magni, Anca Simioniuc, Roberto Ricci, and Frank Lloyd Dini
- Subjects
Heart failure ,mid-range ejection fraction ,6-minute walking test ,BNP ,Medicine - Abstract
The prognostic insights of heart failure (HF) with mid-range (40-49%) ejection fraction (HFmrEF) are not fully elucidated. We investigated whether the six-minutes walking test (6MWT) and brain natriuretic peptide (BNP) are predictive of outcome across the spectrum of LV systolic dysfunction and whether the HFmrEF cut-off impacts the risk stratification abilities of these tests. We studied 538 outpatients, aged 70±12 years, 28% females, with stable chronic HF and EF
- Published
- 2019
- Full Text
- View/download PDF
26. Long COVID: aspetti nosografici ed epidemiologia clinica
- Author
-
Abrignani, M, Maloberti, A, Temporelli, P, Binaghi, G, Cesaro, A, Ciccirillo, F, Oliva, F, Gabrielli, D, Riccio, C, Gulizia, M, Colivicchi, F, Abrignani M. G., Maloberti A., Temporelli P. L., Binaghi G., Cesaro A., Ciccirillo F., Oliva F., Gabrielli D., Riccio C., Gulizia M. M., Colivicchi F., Abrignani, M, Maloberti, A, Temporelli, P, Binaghi, G, Cesaro, A, Ciccirillo, F, Oliva, F, Gabrielli, D, Riccio, C, Gulizia, M, Colivicchi, F, Abrignani M. G., Maloberti A., Temporelli P. L., Binaghi G., Cesaro A., Ciccirillo F., Oliva F., Gabrielli D., Riccio C., Gulizia M. M., and Colivicchi F.
- Abstract
Recent evidence shows that a range of persistent or new symptoms can manifest after 4-12 weeks in a subset of patients who have recovered from acute SARS-CoV-2 infection, and this condition has been coined long COVID by COVID-19 survivors among social support groups. Long COVID can affect the whole spectrum of people with COVID-19, from those with very mild acute disease to the most severe forms. Like the acute form, long COVID has multisystemic aspects. Patients can manifest with a very heterogeneous multitude of symptoms, including fatigue, post-exertional malaise, dyspnea, cognitive impairment, sleep disturbances, anxiety and depression, muscle pain, brain fog, anosmia/dysgeusia, headache, and limitation of functional capacity, which impact their quality of life. Because of the extreme clinical heterogeneity, and also due to the lack of a shared, specific definition, it is very difficult to know the real prevalence and incidence of this condition. Risk factors for developing long COVID would be female sex, initial severity, and comorbidities. Globally, with the re-emergence of new waves, the population of people infected with SARS-CoV-2 continues to expand rapidly, necessitating a more thorough understanding of potential sequelae of COVID-19. This review summarizes up to date definitions and epidemiological aspects of long COVID.
- Published
- 2022
27. Life Cycle Assessment of Stationary Storage Systems within the Italian Electric Network
- Author
-
Maria Leonor Carvalho, Andrea Temporelli, and Pierpaolo Girardi
- Subjects
lithium-ion batteries ,stationary storage ,life cycle assessment ,environmental impact ,Technology - Abstract
The introduction of stationary storage systems into the Italian electric network is necessary to accommodate the increasing share of energy from non-programmable renewable sources and to reach progressive decarbonization targets. In this framework, a life cycle assessment is a suitable tool to assess environmental impacts during the entire life cycle of stationary storage systems, i.e., their sustainability. A Li-ion battery (lithium–iron–phosphate (LFP), nickel–manganese–cobalt (NMC) 532, and NMC 622) entire life cycle assessment (LCA) based on primary and literature data was performed. The LCA results showed that energy consumption (predominantly during cell production), battery design (particularly binder choice), inventory accuracy, and data quality are key aspects that can strongly affect results. Regarding the battery construction phase, LFP batteries showed better performance than the NMC ones, but when the end-of-life (EoL) stage was included, NMC cell performance became very close to those of LFPs. Sensitivity and uncertainty analyses, done using the Monte Carlo methodology, confirmed that the results (except for the freshwater eutrophication indicator) were characterized by a low dispersion and that the energy mix choice, during the different battery life phases, was able to greatly influence the overall impact. The use of primary and updated data related to battery cell production, like those used in the present paper, was necessary to obtain reliable results, and the application to a European production line is an item of novelty of this paper.
- Published
- 2021
- Full Text
- View/download PDF
28. Role of glucagon-like peptide-1 agonists in obesity and heart failure with preserved ejection fraction
- Author
-
Temporelli, Pier Luigi
- Abstract
Heart failure with preserved ejection fraction (HFpEF) currently represents the majority of all heart failure cases in the community. Glucagon-like peptide-1 agonists represent a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity. This class includes semaglutide. In the available data from the Semaglutide Treatment Effect in People with Obesity (STEP) trials that were done, looking at weight loss effects of semaglutide, there was a 30–40% reduction in C-reactive protein levels, and that suggests that there is a significant anti-inflammatory effect. Recently, the STEP-HFpEF trial enrolled 529 non-diabetic patients with HFpEF and obesity who were randomly assigned to once-weekly semaglutide (2.4 mg) or placebo for 52 weeks. A statistically significant improvement in the quality of life score and in weight loss was observed. Statistically significant improvements were also seen in the 6 min walk distance, levels of C-reactive protein, and N-terminal pro–B-type natriuretic peptide levels. Interestingly, the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity trial has shown that semaglutide produced a consistent reduction of around 20% vs. placebo across major cardiovascular event endpoints over the ∼3-year follow-up in patients with overweight or obesity and cardiovascular disease but not diabetes.
- Published
- 2024
- Full Text
- View/download PDF
29. Andrea Temporelli (Borgomanero, 1973)
- Author
-
Andrea Temporelli
- Subjects
poesía ,andrea temporelli ,Arts in general ,NX1-820 ,Language and Literature - Abstract
Andrea Temporelli nació durante los Años de Plomo, en el mes más cruel, poco después de que en Nueva York Martin Cooper hiciera la primera llamada telefónica de la historia con un móvil y mientras se inauguraba el World Trade Centre, una vez completadas sus dos torres. Hijo de una flor y un pequeño mirlo, a los doce años se decide a entrar en el seminario cuando se entera de que allí tendrá la posibilidad de jugar a fútbol todos los días en un campo de verdad. Saldrá pronto, convencido de que los curas no pondrán nunca las redes en las porterías. Ha escrito libros de poesía como Il cielo di Marte (Einaudi, 2005) y Terramadre (Il Ponte del Sale, 2012), el libro de entrevistas literarias Smarcamenti, affondi e fughe (Ladolfi, 2016) y la novela Tutte le voci di questo aldilà (Guaraldi, 2015). Vive en: www.andreatemporelli.com
- Published
- 2017
30. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study.
- Author
-
De Luca, Leonardo, Temporelli, Pier Luigi, Gulizia, Michele Massimo, Gonzini, Lucio, Ammaturo, Tiziana Anita, Tedesco, Luigi, Pede, Silvia, Oliva, Fabrizio, Gabrielli, Domenico, Colivicchi, Furio, and Averna, Maurizio R.
- Abstract
Elevated triglyceride (TG) levels seem to identify subjects at increased cardiovascular risk, independent of LDL-C levels. We sought to evaluate the predictive role of hypertriglyceridemia, defined as TG levels ≥150 mg/dl, in very high risk (VHR) patients with chronic coronary syndromes (CCS) treated with statins. Using the data from the STable Coronary Artery Diseases RegisTry (START) study, an Italian nationwide registry, we assessed the association between the TG levels and baseline clinical characteristics, pharmacological treatment and major adverse cardio-cerebrovascular events (MACCE) at 1 year in a large cohort of statin-treated patients at VHR. Of the 4751 consecutive patients with CCS enrolled in the registry and classified as VHR, 2652 (55.8%) had TG values available (mean 120.6 ± 54.9) and were treated with at least a statin at baseline: 2019 (76.1%) with TG < 150 and 633 (23.9%) with TG ≥ 150 mg/dl. At 1 year from enrolment, MACCE occurred in 168 (6.3%) patients, without differences between the two groups of TG (5.9 vs 7.6%; p = 0.14). At multivariable analysis, hypertriglyceridemia did not result as independent predictor of the MACCE (hazard ratio: 1.16; 95% confidence intervals: 0.82–1.64; p = 0.42). In the present large, nationwide cohort of consecutive CCS patients at VHR with statin-controlled LDL-C levels, hypertriglyceridemia was present in around 24% of cases and did not result as predictor of MACCE at 1 year. Further studies with a longer follow-up and larger sample size are needed to better define the prognostic role of TG levels when intensive LDL lowering therapies are used. • The role of hypertriglyceridemia, in very high-risk patients treated with statins has been poorly analysed in an Italian population. • At 1 year, MACCE occurred in 168 (6.3%) patients, without differences between patients with TG < 150 or ≥150 mg/dl (5.9 vs 7.6%; p = 0.14). • At multivariable analysis, hypertriglyceridemia did not result as independent predictor of the MACCE (HR: 1.16; 95% CI: 0.82–1.64; p = 0.42). • Further studies with a longer follow-up and larger sample size in an Italian population are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
31. Considerations about a Counseling experience in the Faculty of Engineering-Universidad Nacional de Entre Ríos.
- Author
-
M. Perassi and Azul Doval Temporelli
- Subjects
tutoría ,orientación pedagógica ,orientación profesional ,asesoramiento ,elección profesional ,universidad ,Education - Abstract
The present work presents the different strategies and instruments concerning Vocational guidance that have been implemented at a state university in Argentina for ten years, together with an analysis of the most significant factors that have been approached within this space. The Office of Educational Guidance and Career Counseling is an area within the university that encompasses Education professionals and Psychologists, who work co-operatively with teachers, alumni, administrative and faculty authorities. At University level, Vocational guidance is a powerful tool that enables specialists to work on different underlying issues, which relate to the vocational decisions students take, especially during the entrance and graduation stages. It is at university where, apart from education, social interaction becomes possible, thus enabling the establishment of spaces that foster interaction with others, and that allow for the provision of support in the resolution of everyday concerns. The strategies and instruments that are here presented include: open days for future undergraduates; advice on how to settle-down; undergraduate vocational orientation surveys; student mentoring schemes; tutoring; workshops for learners in the first years, workshops for learners in the more advanced courses; brief questionnaires on vocational decisions; and individual interviews. As well as this, reference is here made to more informal and casual meetings given that these can frequently allow for students to express their views concerning their individual situations in particular. This experience shows that there are a number of ways in which Vocational guidance can be approached at University, and that this is especially so given that career choices are always under development, and that the choice does not take place linearly.
- Published
- 2016
- Full Text
- View/download PDF
32. LCA of electricity networks: a review
- Author
-
Gargiulo, Alessia, Girardi, Pierpaolo, and Temporelli, Andrea
- Published
- 2017
- Full Text
- View/download PDF
33. Life Cycle Assessment of Electric Vehicle Batteries: An Overview of Recent Literature
- Author
-
Andrea Temporelli, Maria Leonor Carvalho, and Pierpaolo Girardi
- Subjects
battery electric vehicles ,environmental impacts ,life cycle assessment ,review ,Technology - Abstract
In electric and hybrid vehicles Life Cycle Assessments (LCAs), batteries play a central role and are in the spotlight of scientific community and public opinion. Automotive batteries constitute, together with the powertrain, the main differences between electric vehicles and internal combustion engine vehicles. For this reason, many decision makers and researchers wondered whether energy and environmental impacts from batteries production, can exceed the benefits generated during the vehicle’s use phase. In this framework, the purpose of the present literature review is to understand how large and variable the main impacts are due to automotive batteries’ life cycle, with particular attention to climate change impacts, and to support researchers with some methodological suggestions in the field of automotive batteries’ LCA. The results show that there is high variability in environmental impact assessment; CO2eq emissions per kWh of battery capacity range from 50 to 313 g CO2eq/kWh. Nevertheless, either using the lower or upper bounds of this range, electric vehicles result less carbon-intensive in their life cycle than corresponding diesel or petrol vehicles.
- Published
- 2020
- Full Text
- View/download PDF
34. Additive Value of Biomarkers and Echocardiography to Stratify the Risk of Death in Heart Failure Patients with Reduced Ejection Fraction
- Author
-
Calogero Falletta, Francesco Clemenza, Catherine Klersy, Valentina Agnese, Diego Bellavia, Gabriele Di Gesaro, Chiara Minà, Giuseppe Romano, Pier Luigi Temporelli, Frank Lloyd Dini, Andrea Rossi, Claudia Raineri, Annalisa Turco, Egidio Traversi, and Stefano Ghio
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background. Risk stratification is a crucial issue in heart failure. Clinicians seek useful tools to tailor therapies according to patient risk. Methods. A prospective, observational, multicenter study on stable chronic heart failure outpatients with reduced left ventricular ejection fraction (HFrEF). Baseline demographics, blood, natriuretic peptides (NPs), high-sensitivity troponin I (hsTnI), and echocardiographic data, including the ratio between tricuspid annular plane excursion and systolic pulmonary artery pressure (TAPSE/PASP), were collected. Association with death for any cause was analyzed. Results. Four hundred thirty-one (431) consecutive patients were enrolled in the study. Fifty deaths occurred over a median follow-up of 32 months. On the multivariable Cox model analysis, TAPSE/PASP ratio, number of biomarkers above the threshold values, and gender were independent predictors of death. Both the TAPSE/PASP ratio ≥0.36 and TAPSE/PASP unavailable groups had a three-fold decrease in risk of death in comparison to the TAPSE/PASP ratio
- Published
- 2019
- Full Text
- View/download PDF
35. Cardiac Prevention and Rehabilitation '3.0': From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)
- Author
-
Roberto F.E. Pedretti, Francesco Fattirolli, Raffaele Griffo, Marco Ambrosetti, Elisabetta Angelino, Silvia Brazzo, Ugo Corrà, Nicolò Dasseni, Pompilio Faggiano, Giuseppe Favretto, Oreste Febo, Marina Ferrari, Francesco Giallauria, Cesare Greco, Manuela Iannucci, Maria Teresa La Rovere, Mario Mallardo, Antonio Mazza, Massimo Piepoli, Carmine Riccio, Simonetta Scalvini, Luigi Tavazzi, Pier Luigi Temporelli, and Gian Francesco Mureddu
- Subjects
Cardiac rehabilitation ,secondary prevention ,Medicine - Abstract
Cardiac rehabilitation (CR) is the subspecialty of clinical cardiology dedicated to the treatment of cardiac patients, early and in the long term after an acute event. The aim of CR is to improve both quality of life and prognosis through prognostic stratification, clinical stabilization and optimization of therapy (pharmacological and non), management of comorbidities, treatment of disability, as well as through the provision and reinforcement of secondary prevention interventions and maintenaince of adherence to treatment. The mission of CR has changed over time. Once centered on the acute phase, aimed primarily at short-term survival, the healthcare of cardiac patients now increasingly involves the chronic phase where the challenge is to guarantee continuity and quality of care in the medium and long-term. The aim of the present position paper is to provide the state-of-the-art of CR in Italy, discussing its trengths and weaknesses as well as future perspectives.
- Published
- 2018
- Full Text
- View/download PDF
36. Obesity and Malnutrition: Impact of Habitat and Living Conditions in Adult Urban Population in Argentina
- Author
-
Karina Temporelli and Valentina Viego
- Subjects
Malnutrition ,obesity ,habits ,Socioeconomic Condition ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introduction: malnutrition refers to imbalances (either deficit or excess) in energy intake, protein and / or nutrients including underweight and obesity. The aim of this work is identify the contribution of individual factors, habits and life conditions in nutritional status. Material and methods: estimates of relative risk ratios are obtained from a multinomial logistic model using microdata from the National Survey of Risk Factors conducted in 2005 and 2009 in Argentinean‘ cities among adult population. Results: malnutrition is associated with constitutive and socioeconomic variables, while habits are also important in the obesity case. Discussion: both types of problems coexist in Argentine due to high heterogeneity in life styles, turning difficult the design of public interventions aimed to solve them. This complexity highlights the importance of a careful and specific multidimensional approach (medical, social, economical).
- Published
- 2015
- Full Text
- View/download PDF
37. Echo and BNP serial assessment in ambulatory heart failure care: Data on loop diuretic use and renal function
- Author
-
Frank Lloyd Dini, Anca Simioniuc, Erberto Carluccio, Stefano Ghio, Andrea Rossi, Paolo Biagioli, Gianpaolo Reboldi, Gian Giacomo Galeotti, Fei Lu, Cornelia Zara, Gillian Whalley, and Pier Luigi Temporelli
- Subjects
Heart failure ,Echocardiography ,Natriuretic peptides ,Loop diuretics ,Renal function ,Computer applications to medicine. Medical informatics ,R858-859.7 ,Science (General) ,Q1-390 - Abstract
We compared the follow-up data on loop diuretic use and renal function, as assessed by serum creatinine levels, and the estimated glomerular filtration rate (eGFR), of two groups of consecutive ambulatory HF patients: 1) the clinically-guided group, in which management was clinically driven based on the institutional protocol of the HF Unit of the Cardiovascular and Thoracic Department of Pisa (standard of care) and 2) the echo and B-type natriuretic peptide (BNP) guided group (patients conforming to the protocol of the Network Labs Ultrasound (NEBULA) in HF Study Group: Pisa, Perugia, Pavia; Verona, Auckland, and Veruno), in which therapy was delivered according to the serial assessment of BNP and echocardiography. Patients whose follow-up was based on standard of care had a significant higher prevalence of worsening renal function, that was likely related to higher diuretic dosages, whilst, a better management of renal function was observed in the echo-BNP-guided group. The data is related to “Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients” (A. Simioniuc, E. Carluccio, S. Ghio, A. Rossi, P. Biagioli, G. Reboldi, G.G. Galeotti, F. Lu, C. Zara, G. Whalley, P.G. Temporelli, F.L. Dini, 2016; K.J. Harjai, H.K. Dinshaw, E. Nunez, M. Shah, H. Thompson, T. Turgut, H.O. Ventura, 1999; A. Ahmed, A. Husain, T.E. Love, G. Gambassi, L.J. Dell׳Italia, G.S. Francis, M. Gheorghiade, R.M. Allman, S. Meleth, R.C. Bourge, 2006) [1–3].
- Published
- 2016
- Full Text
- View/download PDF
38. Correction: Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
- Author
-
Stefano Ghio, Gabriele Crimi, Silvia Pica, Pier Luigi Temporelli, Massimo Boffini, Mauro Rinaldi, Claudia Raineri, Laura Scelsi, Massimo Pistono, Rossana Totaro, Stefania Guida, and Luigi Oltrona Visconti
- Subjects
Medicine ,Science - Abstract
[This corrects the article DOI: 10.1371/journal.pone.0188383.].
- Published
- 2018
- Full Text
- View/download PDF
39. Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study.
- Author
-
Leonardo De Luca, Pier Luigi Temporelli, Donata Lucci, Furio Colivicchi, Paolo Calabrò, Carmine Riccio, Antonio Amico, Franco Mascia, Emanuele Proia, Andrea Di Lenarda, Michele Massimo Gulizia, and START Investigators
- Subjects
Medicine ,Science - Abstract
Data on contemporary management patterns of angina in patients with stable coronary artery disease (CAD) are scarce. We sought to describe the current presentation, management, and quality of life of stable CAD patients with or without angina, using the data from the START (STable Coronary Artery Diseases RegisTry) study. START was a prospective, observational, nationwide study aimed to evaluate the presentation, management, treatment and quality of life of stable CAD presenting to cardiologists during outpatient visits or discharged from cardiology wards. Among the 5070 consecutive stable CAD patients enrolled in 183 participating centers over a 3-month period, 3714 (73.2%) had no angina and 1356 (26.8%) presented with angina. Patients with angina underwent more frequently coronary angiography (92.7% vs 84.9%; p
- Published
- 2018
- Full Text
- View/download PDF
40. Exercise gas exchange in continuous-flow left ventricular assist device recipients.
- Author
-
Alessandro Mezzani, Massimo Pistono, Piergiuseppe Agostoni, Andrea Giordano, Marco Gnemmi, Alessandro Imparato, Pierluigi Temporelli, and Ugo Corrà
- Subjects
Medicine ,Science - Abstract
Exercise ventilation/perfusion matching in continuous-flow left ventricular assist device recipients (LVAD) has not been studied systematically. Twenty-five LVAD and two groups of 15 reduced ejection fraction chronic heart failure (HFrEF) patients with peak VO2 matched to that of LVAD (HFrEF-matched) and ≥14 ml/kg/min (HFrEF≥14), respectively, underwent cardiopulmonary exercise testing with arterial blood gas analysis, echocardiogram and venous blood sampling for renal function evaluation. Arterial-end-tidal PCO2 difference (P(a-ET)CO2) and physiological dead space-tidal volume ratio (VD/VT) were used as descriptors of alveolar and total wasted ventilation, respectively. Tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio (TAPSE/PASP) and blood urea nitrogen/creatinine ratio were calculated in all patients and used as surrogates of right ventriculo-arterial coupling and circulating effective volume, respectively. LVAD and HFrEF-matched showed no rest-to-peak change of P(a-ET)CO2 (4.5±2.4 vs. 4.3±2.2 mm Hg and 4.1±1.4 vs. 3.8±2.5 mm Hg, respectively, both p >0.40), whereas a decrease was observed in HFrEF≥14 (6.5±3.6 vs. 2.8±2.0 mm Hg, p
- Published
- 2018
- Full Text
- View/download PDF
41. Socioeconomic status and self-reported chronic diseases among Argentina’s adult population: results based on multivariate probability models
- Author
-
Valentina Viego and Karina Temporelli
- Subjects
hypertension ,diabetes ,cholesterolemia ,chronic diseases ,social factors ,Public aspects of medicine ,RA1-1270 - Abstract
Background. Hypertension, diabetes and hypercholesterolemia are the most frequent and diagnosed chronic diseases in Argentina. They contribute largely to the burden of chronic disease and they are strongly influenced by a small number of risk factors. These risk factors are all modifiable at the population and individual level and offer major prospects for their prevention. We are interested in socioeconomic determinants of prevalence of those 3 specific diseases. Design and methods. We estimate 3-equation probit model, combined with 3 separate probit estimations and a probit-based Heckman correction considering possible sample selection bias. Estimations were carried out using secondary self-reported data coming from the 2013 Risk Factor National Survey. Results. We find a negative association between socioeconomic status and prevalence of hypertension, cholesterolemia and diabetes; main increases concentrate in the transition from low to high SES in hypertension and diabetes. In cholesterol, the major effect takes place when individual crosses from low to middle SES and then vanishes. Anyway, in Argentina SES exhibit and independent effect on chronic diseases apart from those based on habits and body weight. Conclusions. Public strategies to prevent chronic diseases must be specially targeted at women, poorest households and the least educated individuals in order to achieve efficacy. Also, as the probability of having a condition related to excessive blood pressure, high levels of cholesterol or glucose in the blood do not increase proportionally with age, so public campaigns promoting healthy diets, physical activity and medical checkups should be focused on young individuals to facilitate prophylaxis.
- Published
- 2017
- Full Text
- View/download PDF
42. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial
- Author
-
Marco Dauriz, Giovanni Targher, Pier Luigi Temporelli, Donata Lucci, Lucio Gonzini, Gian Luigi Nicolosi, Roberto Marchioli, Gianni Tognoni, Roberto Latini, Franco Cosmi, Luigi Tavazzi, and Aldo Pietro Maggioni
- Subjects
chronic heart failure ,diabetes mellitus ,glycemic control ,heart failure ,mortality ,prediabetes ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundThe independent prognostic impact of diabetes mellitus (DM) and prediabetes mellitus (pre‐DM) on survival outcomes in patients with chronic heart failure has been investigated in observational registries and randomized, clinical trials, but the results have been often inconclusive or conflicting. We examined the independent prognostic impact of DM and pre‐DM on survival outcomes in the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) trial. Methods and ResultsWe assessed the risk of all‐cause death and the composite of all‐cause death or cardiovascular hospitalization over a median follow‐up period of 3.9 years among the 6935 chronic heart failure participants of the GISSI‐HF trial, who were stratified by presence of DM (n=2852), pre‐DM (n=2013), and non‐DM (n=2070) at baseline. Compared with non‐DM patients, those with DM had remarkably higher incidence rates of all‐cause death (34.5% versus 24.6%) and the composite end point (63.6% versus 54.7%). Conversely, both event rates were similar between non‐DM patients and those with pre‐DM. Cox regression analysis showed that DM, but not pre‐DM, was associated with an increased risk of all‐cause death (adjusted hazard ratio, 1.43; 95% CI, 1.28–1.60) and of the composite end point (adjusted hazard ratio, 1.23; 95% CI, 1.13–1.32), independently of established risk factors. In the DM subgroup, higher hemoglobin A1c was also independently associated with increased risk of both study outcomes (all‐cause death: adjusted hazard ratio, 1.21; 95% CI, 1.02–1.43; and composite end point: adjusted hazard ratio, 1.14; 95% CI, 1.01–1.29, respectively). ConclusionsPresence of DM was independently associated with poor long‐term survival outcomes in patients with chronic heart failure. Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00336336.
- Published
- 2017
- Full Text
- View/download PDF
43. Trends in acute myocardial infarction mortality in the European Union, 2012–2020
- Author
-
Zuin, Marco, Rigatelli, Gianluca, Temporelli, Pierluigi, Di Fusco, Stefania Angela, Colivicchi, Furio, Pasquetto, Giampaolo, and Bilato, Claudio
- Abstract
Graphical abstract
- Published
- 2023
- Full Text
- View/download PDF
44. Consideraciones sobre una experiencia en Orientación en la Facultad de Ingeniería - Universidad Nacional de Entre Ríos
- Author
-
Marisol Perassi and Azul Doval Temporelli
- Subjects
Tutoría ,Orientación pedagógica ,Orientación profesional ,Asesoramiento ,Elección profesional ,Universidad ,Education - Abstract
Este trabajo presenta diferentes instancias y dispositivos de Orientación que se han implementado en una institución universitaria pública argentina durante diez años, y analiza los temas que aparecen como más significativos y que se abordan allí.En el Área de Asesoría Pedagógica y Orientación Vocacional actualmente trabajan profesionales de Educación y de Psicología, y colaboran activamente docentes, egresados, autoridades y administrativos de la institución.En el ámbito de la universidad, la Orientación Vocacional (OV) es una potente herramienta para trabajar con los estudiantes (particularmente al ingreso y egreso), cuestiones que subyacen y se relacionan con sus elecciones vocacionales. En la Universidad, además de la formación, también se hace posible el intercambio social, y por eso se considera importante colaborar en la construcción de espacios que favorezcan el encuentro con otros, y que posibiliten el apoyo para resolver cuestiones comunes que preocupan.Las instancias y dispositivos que se presentan aquí son: jornadas de orientación para futuros ingresantes, ambientación universitaria, encuestas vocacionales a ingresantes, tutoría entre pares, talleres destinados a estudiantes de los primeros años, talleres destinados a estudiantes avanzados, cuestionarios breves sobre la situación vocacional y entrevistas personales. También se realiza una referencia a encuentros informales y casuales, por considerarse que éstos muchas veces posibilitan que los estudiantes se expresen respecto de su situación particular.Esta experiencia permite ver que hay muchos modos de abordar la OV en la Universidad y esto es así principalmente porque las elecciones vocacionales siempre están en construcción, y esa construcción no se realiza de manera lineal.ABSTRACTThe present work presents the different strategies and instruments concerning Vocational guidance that have been implemented at a state university in Argentina for ten years, together with an analysis of the most significant factors that have been approached within this space.The Office of Educational Guidance and Career Counseling is an area within the university that encompasses Education professionals and Psychologists, who work co-operatively with teachers, alumni, administrative and Faculty authorities.At University level, Vocational guidance is a powerful tool that enables specialists to work on different underlying issues, which relate to the vocational decisions students take, especially during the entrance and graduation stages. It is at university where, apart from education, social interaction becomes possible, thus enabling the establishment of spaces that foster interaction with others, and that allow for the provision of support in the resolution of everyday concerns.The strategies and instruments that are here presented include: open days for future undergraduates; advice on how to settle-down; undergraduate vocational orientation surveys; student mentoring schemes; tutoring; workshops for learners in the first years, workshops for learners in the more advanced courses; brief questionnaires on vocational decisions; and individual interviews. As well as this, reference is here made to more informal and casual meetings given that these can frequently allow for students to express their views concerning their individual situations in particular.This experience shows that there are a number of ways in which Vocational guidance can be approached at University, and that this is especially so given that career choices are always under development, and that the choice does not take place linearly.
- Published
- 2014
45. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry
- Author
-
De Luca, L, Formigli, D, Meessen, J, Uguccioni, M, Cosentino, N, Paolillo, C, Di Lenarda, A, Colivicchi, F, Gabrielli, D, Gulizia, M, Scherillo, M, Maras, P, Ramani, F, Falcone, C, Passarelli, I, Mauri, S, Calabro, P, Bianchi, R, Di Palma, G, Mascia, F, Vetrano, A, Fusco, A, Proia, E, Aiello, A, Tomai, F, Licitra, R, Petrolini, A, Bosco, B, Magliari, F, Callerame, M, Mazzella, T, Lettica, G, Coco, G, Incao, F, Marinacci, L, D'Addario, S, Tartaglione, S, Ubaldi, S, Sanchez, F, Costa, P, Manca, G, Failla, M, Procaccini, V, Senni, M, Luminita, E, Bonomo, P, Mossa, C, Corda, S, Colavita, A, Trevisonno, G, Vizzari, G, Formaro, C, Nalin, I, De Rosa, F, Fontana, F, Fuscaldo, G, Passamonti, E, Bertella, E, Calvaruso, E, Varani, E, Tani, F, Cicchitelli, G, Paoloni, P, Marziali, A, Campo, G, Tebaldi, M, Biscaglia, S, Di Biase, M, Brunetti, N, Gallotta, A, Mattei, L, Marini, R, Balsemin, F, D'Urbano, M, Naio, R, Vicinelli, P, Arena, G, Mazzini, M, Gigli, N, Miserrafiti, B, Monopoli, A, Mortara, A, Delfino, P, Chioffi, M, Marino, P, Gravellone, M, Barbieri, L, Ledda, A, Geraci, G, Carmina, M, Raisaro, A, Di Giacomo, C, Somaschini, A, Fasano, M, Sannazzaro, M, Arcieri, R, Pantaleoni, M, Leuzzi, C, Gorlato, G, Greco, G, Chiera, A, Ammaturo, T, Malanchini, G, Del Corral, M, Tedesco, L, Pede, S, Urso, L, Piscione, F, Galasso, G, Provasoli, S, Fattore, L, Lucca, G, Cresti, A, Cardillo, A, Fera, M, Vennettilli, F, Gaudio, C, Paravati, V, Caldarola, P, Locuratolo, N, Verlato, R, De Conti, F, Turiano, G, Preti, G, Moretti, L, Silenzi, S, Colonna, G, Picciolo, A, Nicosia, A, Cascone, C, Di Sciascio, G, Mangiacapra, F, Russo, A, Mastroianno, S, Esposito, G, Cosmi, F, D'Orazio, S, Costantini, C, Lanari, A, De Rosa, P, Esposito, L, Bilato, C, Dalla Valle, C, Ceresa, M, Colombo, E, Pennisi, V, Casciola, G, Driussi, M, Bisceglia, T, Scalvini, S, Rivadossi, F, Volpe, M, Comito, F, Scorzoni, D, Grimoldi, P, Lagioia, R, Santoro, D, De Cesare, N, Comotti, T, Poli, A, Martina, P, Musolino, M, Multari, E, Bilardo, G, Scalchi, G, Olivieri, C, Caranci, F, Pavan, D, Ganci, G, Mariani, A, Falchetti, E, Lanzillo, T, Caccavale, A, Bongo, A, Rizzi, A, Favilli, R, Maffei, S, Mallardo, M, Fulgione, C, Bordin, F, Bonmassari, R, Battaia, E, Puzzo, A, Vianello, G, D'Arpino, A, Romei, M, Pajes, G, Petronzelli, S, Ghezzi, F, Brigido, S, Pignatelli, L, Brscic, E, Sori, P, Russo, M, Biancolillo, E, Ignone, G, De Giorgio, N, Campaniello, C, Ponticelli, P, Margonato, A, Gerosa, S, Cutaia, A, Casalicchio, C, Bartolomucci, F, Larosa, C, Spadafina, T, Putignano, A, Se Cristofaro, R, Bernardi, L, Sommariva, L, Celestini, A, Bertucci, C, Marchetti, M, Franceschini Grisolia, E, Ammendolea, C, Carini, M, Scipione, P, Politano, M, Rubino, G, Reina, C, Peccerillo, N, Paloscia, L, D'Alleva, A, Petacchi, R, Pignalosa, M, Lucchetti, D, Di Palma, F, La Mastra, R, Amico, A, De Filippis, M, Fontanella, B, Zanini, G, Casolo, G, Del Meglio, J, Parato, V, Genovesi, E, D'Alimonte, A, Miglioranza, A, Alessandri, N, Moscariello, F, Mauro, C, Sasso, A, Caso, P, Petrillo, C, Napoletano, C, Paparoni, S, Bernardo, V, Serdoz, R, Rotunno, R, Oppo, I, Aloisio, A, Aurelio, A, Licciardello, G, Cassaniti, L, Francese, G, Marcassa, C, Temporelli, P, Villani, R, Zorzoli, F, Mileto, F, De Vecchis, M, Scolozzi, D, Lupi, G, Caruso, D, Rebulla, E, La Fata, B, Anselmi, M, Girardi, P, Borruso, E, Ferrantelli, G, Sassone, B, Bressan, S, Capriolo, M, Pelissero, E, Piancastelli, M, Gobbi, M, Cocco, F, Bruno, M, Berti, S, Lo Surdo, G, Tanzi, P, De Rosa, R, Vilei, E, De Iaco, M, Grassi, G, Zanella, C, Marullo, L, Alfano, G, Pelaggi, P, Talarico, R, Tuccillo, B, Irace, L, Proietti, F, Di Croce, G, Di Lorenzo, L, Zarrilli, A, Bongini, M, Ranise, A, Aprile, A, Fornengo, C, Capogrosso, V, Tranghese, A, Golia, B, Marziano, A, Roncon, L, Picariello, C, Bagni, E, Leci, E, Gregorio, G, Gatto, F, Piemonte, F, Gervasio, F, Navazio, A, Guerri, E, Belmonte, E, Marino, F, Di Belardino, N, Di Nuzzo, M, Epifani, M, Comolatti, G, Conconi, B, Benea, D, Casu, G, Merella, P, Ammirati, M, Corrado, V, Spagnolo, D, Caico, S, Bonizzato, S, Margheri, M, Corrado, L, Antonicelli, R, Ferrigno, C, Merlino, A, Nassiacos, D, Antonelli, A, Marchese, A, Villella, A, Bechi, S, Lo Bianco, F, Bedogni, F, Negro, L, Donato, L, Statile, D, Cassin, M, Fedele, F, Granatelli, A, Calcagno, S, Politi, A, Pani, A, De Luca L., Formigli D., Meessen J., Uguccioni M., Cosentino N., Paolillo C., Di Lenarda A., Colivicchi F., Gabrielli D., Gulizia M. M., Scherillo M., Maras P., Ramani F., Falcone C., Passarelli I., Mauri S., Calabro P., Bianchi R., Di Palma G., Mascia F., Vetrano A., Fusco A., Proia E., Aiello A., Tomai F., Licitra R., Petrolini A., Bosco B., Magliari F., Callerame M., Mazzella T., Lettica G. V., Coco G., Incao F., Marinacci L., D'Addario S., Tartaglione S. N., Ubaldi S., Sanchez F. A., Costa P., Manca G., Failla M., Procaccini V., Senni M., Luminita E. M., Bonomo P., Mossa C., Corda S., Colavita A. R., Trevisonno G., Vizzari G., Formaro C., Nalin I. L., De Rosa F. M., Fontana F., Fuscaldo G. F., Passamonti E., Bertella E., Calvaruso E. V., Varani E., Tani F., Cicchitelli G., Paoloni P., Marziali A., Campo G., Tebaldi M., Biscaglia S., Di Biase M., Brunetti N. D., Gallotta A. M., Mattei L., Marini R., Balsemin F., D'Urbano M., Naio R., Vicinelli P., Arena G., Mazzini M., Gigli N., Miserrafiti B., Monopoli A., Mortara A., Delfino P., Chioffi M. M., Marino P., Gravellone M., Barbieri L., Ledda A., Geraci G., Carmina M. G., Raisaro A. E., Di Giacomo C., Somaschini A., Fasano M. L., Sannazzaro M., Arcieri R., Pantaleoni M., Leuzzi C., Gorlato G., Greco G., Chiera A., Ammaturo T. A., Malanchini G., Del Corral M. P., Tedesco L., Pede S., Urso L. G., Piscione F., Galasso G., Provasoli S., Fattore L., Lucca G., Cresti A., Cardillo A., Fera M. S., Vennettilli F., Gaudio C., Paravati V., Caldarola P., Locuratolo N., Verlato R., De Conti F., Turiano G., Preti G., Moretti L., Silenzi S., Colonna G., Picciolo A., Nicosia A., Cascone C., Di Sciascio G., Mangiacapra F., Russo A., Mastroianno S., Esposito G., Cosmi F., D'Orazio S., Costantini C., Lanari A., De Rosa P., Esposito L., Bilato C., Dalla Valle C., Ceresa M., Colombo E., Pennisi V., Casciola G., Driussi M., Bisceglia T., Scalvini S., Rivadossi F., Volpe M., Comito F., Scorzoni D., Grimoldi P., Lagioia R., Santoro D., De Cesare N., Comotti T., Poli A., Martina P., Musolino M. F., Multari E. I., Bilardo G., Scalchi G., Olivieri C., Caranci F., Pavan D., Ganci G., Mariani A., Falchetti E., Lanzillo T., Caccavale A., Bongo A. S., Rizzi A., Favilli R., Maffei S., Mallardo M., Fulgione C., Bordin F., Bonmassari R., Battaia E., Puzzo A., Vianello G., D'Arpino A., Romei M., Pajes G., Petronzelli S., Ghezzi F., Brigido S., Pignatelli L., Brscic E., Sori P., Russo M., Biancolillo E., Ignone G., De Giorgio N. A., Campaniello C., Ponticelli P., Margonato A., Gerosa S., Cutaia A., Casalicchio C., Bartolomucci F., Larosa C., Spadafina T., Putignano A., Se Cristofaro R., Bernardi L., Sommariva L., Celestini A., Bertucci C. M., Marchetti M., Franceschini Grisolia E., Ammendolea C., Carini M., Scipione P., Politano M., Rubino G., Reina C., Peccerillo N., Paloscia L., D'Alleva A., Petacchi R., Pignalosa M., Lucchetti D., Di Palma F., La Mastra R. A., Amico A. F., De Filippis M., Fontanella B., Zanini G., Casolo G., Del Meglio J., Parato V. M., Genovesi E., D'Alimonte A., Miglioranza A., Alessandri N., Moscariello F., Mauro C., Sasso A., Caso P., Petrillo C., Napoletano C., Paparoni S. R., Bernardo V., Serdoz R., Rotunno R., Oppo I., Aloisio A., Aurelio A., Licciardello G., Cassaniti L., Francese G. M., Marcassa C., Temporelli P. L., Villani R., Zorzoli F., Mileto F., De Vecchis M., Scolozzi D., Lupi G., Caruso D., Rebulla E., La Fata B., Anselmi M., Girardi P., Borruso E., Ferrantelli G., Sassone B., Bressan S., Capriolo M., Pelissero E., Piancastelli M., Gobbi M., Cocco F., Bruno M. G., Berti S., Lo Surdo G., Tanzi P., De Rosa R., Vilei E., De Iaco M. R., Grassi G., Zanella C., Marullo L., Alfano G., Pelaggi P., Talarico R., Tuccillo B., Irace L., Proietti F., Di Croce G., Di Lorenzo L., Zarrilli A., Bongini M., Ranise A., Aprile A., Fornengo C., Capogrosso V., Tranghese A., Golia B., Marziano A., Roncon L., Picariello C., Bagni E., Leci E., Gregorio G., Gatto F., Piemonte F., Gervasio F., Navazio A., Guerri E., Belmonte E., Marino F., Di Belardino N., Di Nuzzo M. R., Epifani M., Comolatti G., Conconi B., Benea D., Casu G., Merella P., Ammirati M. A., Corrado V. M., Spagnolo D., Caico S. I., Bonizzato S., Margheri M., Corrado L., Antonicelli R., Ferrigno C., Merlino A., Nassiacos D., Antonelli A., Marchese A., Villella A., Bechi S., Lo Bianco F., Bedogni F., Negro L., Donato L., Statile D., Cassin M., Fedele F., Granatelli A., Calcagno S., Politi A., Pani A., De Luca, L, Formigli, D, Meessen, J, Uguccioni, M, Cosentino, N, Paolillo, C, Di Lenarda, A, Colivicchi, F, Gabrielli, D, Gulizia, M, Scherillo, M, Maras, P, Ramani, F, Falcone, C, Passarelli, I, Mauri, S, Calabro, P, Bianchi, R, Di Palma, G, Mascia, F, Vetrano, A, Fusco, A, Proia, E, Aiello, A, Tomai, F, Licitra, R, Petrolini, A, Bosco, B, Magliari, F, Callerame, M, Mazzella, T, Lettica, G, Coco, G, Incao, F, Marinacci, L, D'Addario, S, Tartaglione, S, Ubaldi, S, Sanchez, F, Costa, P, Manca, G, Failla, M, Procaccini, V, Senni, M, Luminita, E, Bonomo, P, Mossa, C, Corda, S, Colavita, A, Trevisonno, G, Vizzari, G, Formaro, C, Nalin, I, De Rosa, F, Fontana, F, Fuscaldo, G, Passamonti, E, Bertella, E, Calvaruso, E, Varani, E, Tani, F, Cicchitelli, G, Paoloni, P, Marziali, A, Campo, G, Tebaldi, M, Biscaglia, S, Di Biase, M, Brunetti, N, Gallotta, A, Mattei, L, Marini, R, Balsemin, F, D'Urbano, M, Naio, R, Vicinelli, P, Arena, G, Mazzini, M, Gigli, N, Miserrafiti, B, Monopoli, A, Mortara, A, Delfino, P, Chioffi, M, Marino, P, Gravellone, M, Barbieri, L, Ledda, A, Geraci, G, Carmina, M, Raisaro, A, Di Giacomo, C, Somaschini, A, Fasano, M, Sannazzaro, M, Arcieri, R, Pantaleoni, M, Leuzzi, C, Gorlato, G, Greco, G, Chiera, A, Ammaturo, T, Malanchini, G, Del Corral, M, Tedesco, L, Pede, S, Urso, L, Piscione, F, Galasso, G, Provasoli, S, Fattore, L, Lucca, G, Cresti, A, Cardillo, A, Fera, M, Vennettilli, F, Gaudio, C, Paravati, V, Caldarola, P, Locuratolo, N, Verlato, R, De Conti, F, Turiano, G, Preti, G, Moretti, L, Silenzi, S, Colonna, G, Picciolo, A, Nicosia, A, Cascone, C, Di Sciascio, G, Mangiacapra, F, Russo, A, Mastroianno, S, Esposito, G, Cosmi, F, D'Orazio, S, Costantini, C, Lanari, A, De Rosa, P, Esposito, L, Bilato, C, Dalla Valle, C, Ceresa, M, Colombo, E, Pennisi, V, Casciola, G, Driussi, M, Bisceglia, T, Scalvini, S, Rivadossi, F, Volpe, M, Comito, F, Scorzoni, D, Grimoldi, P, Lagioia, R, Santoro, D, De Cesare, N, Comotti, T, Poli, A, Martina, P, Musolino, M, Multari, E, Bilardo, G, Scalchi, G, Olivieri, C, Caranci, F, Pavan, D, Ganci, G, Mariani, A, Falchetti, E, Lanzillo, T, Caccavale, A, Bongo, A, Rizzi, A, Favilli, R, Maffei, S, Mallardo, M, Fulgione, C, Bordin, F, Bonmassari, R, Battaia, E, Puzzo, A, Vianello, G, D'Arpino, A, Romei, M, Pajes, G, Petronzelli, S, Ghezzi, F, Brigido, S, Pignatelli, L, Brscic, E, Sori, P, Russo, M, Biancolillo, E, Ignone, G, De Giorgio, N, Campaniello, C, Ponticelli, P, Margonato, A, Gerosa, S, Cutaia, A, Casalicchio, C, Bartolomucci, F, Larosa, C, Spadafina, T, Putignano, A, Se Cristofaro, R, Bernardi, L, Sommariva, L, Celestini, A, Bertucci, C, Marchetti, M, Franceschini Grisolia, E, Ammendolea, C, Carini, M, Scipione, P, Politano, M, Rubino, G, Reina, C, Peccerillo, N, Paloscia, L, D'Alleva, A, Petacchi, R, Pignalosa, M, Lucchetti, D, Di Palma, F, La Mastra, R, Amico, A, De Filippis, M, Fontanella, B, Zanini, G, Casolo, G, Del Meglio, J, Parato, V, Genovesi, E, D'Alimonte, A, Miglioranza, A, Alessandri, N, Moscariello, F, Mauro, C, Sasso, A, Caso, P, Petrillo, C, Napoletano, C, Paparoni, S, Bernardo, V, Serdoz, R, Rotunno, R, Oppo, I, Aloisio, A, Aurelio, A, Licciardello, G, Cassaniti, L, Francese, G, Marcassa, C, Temporelli, P, Villani, R, Zorzoli, F, Mileto, F, De Vecchis, M, Scolozzi, D, Lupi, G, Caruso, D, Rebulla, E, La Fata, B, Anselmi, M, Girardi, P, Borruso, E, Ferrantelli, G, Sassone, B, Bressan, S, Capriolo, M, Pelissero, E, Piancastelli, M, Gobbi, M, Cocco, F, Bruno, M, Berti, S, Lo Surdo, G, Tanzi, P, De Rosa, R, Vilei, E, De Iaco, M, Grassi, G, Zanella, C, Marullo, L, Alfano, G, Pelaggi, P, Talarico, R, Tuccillo, B, Irace, L, Proietti, F, Di Croce, G, Di Lorenzo, L, Zarrilli, A, Bongini, M, Ranise, A, Aprile, A, Fornengo, C, Capogrosso, V, Tranghese, A, Golia, B, Marziano, A, Roncon, L, Picariello, C, Bagni, E, Leci, E, Gregorio, G, Gatto, F, Piemonte, F, Gervasio, F, Navazio, A, Guerri, E, Belmonte, E, Marino, F, Di Belardino, N, Di Nuzzo, M, Epifani, M, Comolatti, G, Conconi, B, Benea, D, Casu, G, Merella, P, Ammirati, M, Corrado, V, Spagnolo, D, Caico, S, Bonizzato, S, Margheri, M, Corrado, L, Antonicelli, R, Ferrigno, C, Merlino, A, Nassiacos, D, Antonelli, A, Marchese, A, Villella, A, Bechi, S, Lo Bianco, F, Bedogni, F, Negro, L, Donato, L, Statile, D, Cassin, M, Fedele, F, Granatelli, A, Calcagno, S, Politi, A, Pani, A, De Luca L., Formigli D., Meessen J., Uguccioni M., Cosentino N., Paolillo C., Di Lenarda A., Colivicchi F., Gabrielli D., Gulizia M. M., Scherillo M., Maras P., Ramani F., Falcone C., Passarelli I., Mauri S., Calabro P., Bianchi R., Di Palma G., Mascia F., Vetrano A., Fusco A., Proia E., Aiello A., Tomai F., Licitra R., Petrolini A., Bosco B., Magliari F., Callerame M., Mazzella T., Lettica G. V., Coco G., Incao F., Marinacci L., D'Addario S., Tartaglione S. N., Ubaldi S., Sanchez F. A., Costa P., Manca G., Failla M., Procaccini V., Senni M., Luminita E. M., Bonomo P., Mossa C., Corda S., Colavita A. R., Trevisonno G., Vizzari G., Formaro C., Nalin I. L., De Rosa F. M., Fontana F., Fuscaldo G. F., Passamonti E., Bertella E., Calvaruso E. V., Varani E., Tani F., Cicchitelli G., Paoloni P., Marziali A., Campo G., Tebaldi M., Biscaglia S., Di Biase M., Brunetti N. D., Gallotta A. M., Mattei L., Marini R., Balsemin F., D'Urbano M., Naio R., Vicinelli P., Arena G., Mazzini M., Gigli N., Miserrafiti B., Monopoli A., Mortara A., Delfino P., Chioffi M. M., Marino P., Gravellone M., Barbieri L., Ledda A., Geraci G., Carmina M. G., Raisaro A. E., Di Giacomo C., Somaschini A., Fasano M. L., Sannazzaro M., Arcieri R., Pantaleoni M., Leuzzi C., Gorlato G., Greco G., Chiera A., Ammaturo T. A., Malanchini G., Del Corral M. P., Tedesco L., Pede S., Urso L. G., Piscione F., Galasso G., Provasoli S., Fattore L., Lucca G., Cresti A., Cardillo A., Fera M. S., Vennettilli F., Gaudio C., Paravati V., Caldarola P., Locuratolo N., Verlato R., De Conti F., Turiano G., Preti G., Moretti L., Silenzi S., Colonna G., Picciolo A., Nicosia A., Cascone C., Di Sciascio G., Mangiacapra F., Russo A., Mastroianno S., Esposito G., Cosmi F., D'Orazio S., Costantini C., Lanari A., De Rosa P., Esposito L., Bilato C., Dalla Valle C., Ceresa M., Colombo E., Pennisi V., Casciola G., Driussi M., Bisceglia T., Scalvini S., Rivadossi F., Volpe M., Comito F., Scorzoni D., Grimoldi P., Lagioia R., Santoro D., De Cesare N., Comotti T., Poli A., Martina P., Musolino M. F., Multari E. I., Bilardo G., Scalchi G., Olivieri C., Caranci F., Pavan D., Ganci G., Mariani A., Falchetti E., Lanzillo T., Caccavale A., Bongo A. S., Rizzi A., Favilli R., Maffei S., Mallardo M., Fulgione C., Bordin F., Bonmassari R., Battaia E., Puzzo A., Vianello G., D'Arpino A., Romei M., Pajes G., Petronzelli S., Ghezzi F., Brigido S., Pignatelli L., Brscic E., Sori P., Russo M., Biancolillo E., Ignone G., De Giorgio N. A., Campaniello C., Ponticelli P., Margonato A., Gerosa S., Cutaia A., Casalicchio C., Bartolomucci F., Larosa C., Spadafina T., Putignano A., Se Cristofaro R., Bernardi L., Sommariva L., Celestini A., Bertucci C. M., Marchetti M., Franceschini Grisolia E., Ammendolea C., Carini M., Scipione P., Politano M., Rubino G., Reina C., Peccerillo N., Paloscia L., D'Alleva A., Petacchi R., Pignalosa M., Lucchetti D., Di Palma F., La Mastra R. A., Amico A. F., De Filippis M., Fontanella B., Zanini G., Casolo G., Del Meglio J., Parato V. M., Genovesi E., D'Alimonte A., Miglioranza A., Alessandri N., Moscariello F., Mauro C., Sasso A., Caso P., Petrillo C., Napoletano C., Paparoni S. R., Bernardo V., Serdoz R., Rotunno R., Oppo I., Aloisio A., Aurelio A., Licciardello G., Cassaniti L., Francese G. M., Marcassa C., Temporelli P. L., Villani R., Zorzoli F., Mileto F., De Vecchis M., Scolozzi D., Lupi G., Caruso D., Rebulla E., La Fata B., Anselmi M., Girardi P., Borruso E., Ferrantelli G., Sassone B., Bressan S., Capriolo M., Pelissero E., Piancastelli M., Gobbi M., Cocco F., Bruno M. G., Berti S., Lo Surdo G., Tanzi P., De Rosa R., Vilei E., De Iaco M. R., Grassi G., Zanella C., Marullo L., Alfano G., Pelaggi P., Talarico R., Tuccillo B., Irace L., Proietti F., Di Croce G., Di Lorenzo L., Zarrilli A., Bongini M., Ranise A., Aprile A., Fornengo C., Capogrosso V., Tranghese A., Golia B., Marziano A., Roncon L., Picariello C., Bagni E., Leci E., Gregorio G., Gatto F., Piemonte F., Gervasio F., Navazio A., Guerri E., Belmonte E., Marino F., Di Belardino N., Di Nuzzo M. R., Epifani M., Comolatti G., Conconi B., Benea D., Casu G., Merella P., Ammirati M. A., Corrado V. M., Spagnolo D., Caico S. I., Bonizzato S., Margheri M., Corrado L., Antonicelli R., Ferrigno C., Merlino A., Nassiacos D., Antonelli A., Marchese A., Villella A., Bechi S., Lo Bianco F., Bedogni F., Negro L., Donato L., Statile D., Cassin M., Fedele F., Granatelli A., Calcagno S., Politi A., and Pani A.
- Abstract
Aims Recently, the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial demonstrated that dual therapy reduced cardiovascular outcomes compared with aspirin alone in patients with stable atherosclerotic disease. Methods and We sought to assess the proportion of patients eligible for the COMPASS trial and to compare the epidemiology results and outcome of these patients with those without COMPASS inclusion or with any exclusion criteria in a contemporary, nationwide cohort of patients with stable coronary artery disease. Among the 4068 patients with detailed information allowing evaluation of eligibility, 1416 (34.8%) did not fulfil the inclusion criteria (COMPASS-Not-Included), 841 (20.7%) had exclusion criteria (COMPASS-Excluded), and the remaining 1811 (44.5%) were classified as COMPASS-Like. At 1 year, the incidence of major adverse cardiovascular event (MACE), a composite of cardiovascular death, myocardial infarction, and stroke, was 0.9% in the COMPASS-Not-Included and 2.0% in the COMPASS-Like (P = 0.01), and 5.0% in the COMPASS-Excluded group (P < 0.0001 for all comparisons). Among the COMPASS-Like population, patients with multiple COMPASS enrichment criteria presented a significant increase in the risk of MACE (from 1.0% to 3.3% in those with 1 and >_3 criteria, respectively; P = 0.012), and a modest absolute increase in major bleeding risk (from 0.2% to 0.4%, respectively; P = 0.46). Conclusion In a contemporary real-world cohort registry of stable coronary artery disease, most patients resulted as eligible for the COMPASS. These patients presented a considerable annual risk of MACE that consistently increases in the presence of multiple risk factors.
- Published
- 2021
46. Chronic obstructive pulmonary disease in symptomatic aortic stenosis: a main underlying diagnostic confounder and prognostic factor: P95
- Author
-
Rigolli, M, Rossi, A, Temporelli, P L, Benfari, G, Cioffi, G, Nistri, S, Gaibazzi, N, Guidetti, F, Bafadhel, M, and Faggiano, P
- Published
- 2017
- Full Text
- View/download PDF
47. Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
- Author
-
Stefano Ghio, Gabriele Crimi, Silvia Pica, Pier Luigi Temporelli, Massimo Boffini, Mauro Rinaldi, Claudia Raineri, Laura Scelsi, Massimo Pistono, Rossana Totaro, Stefania Guida, and Luigi Oltrona Visconti
- Subjects
Medicine ,Science - Abstract
The hemodynamic definitions of pulmonary hypertension (PH) in left heart disease have recently been refined to better match the characteristics required to reflect the presence of pulmonary vascular disease. Accordingly, we tested the hypothesis that abnormalities in the stiffness of pulmonary circulation would persist after heart transplantation in patients with combined post-capillary and pre-capillary PH (Cpc-PH) in contrast to those with isolated post-capillary PH (Ipc-PH).We retrospectively analyzed right heart hemodynamics in a cohort of 295 consecutive patients with heart failure and advanced left ventricular systolic dysfunction (LVSD) before and 1 year after heart transplantation.According to their baseline hemodynamic profile, patients were classified as: 75 Cpc-PH, 111 Ipc-PH, and 98 without PH (no-PH), and 11 pre-capillary PH. One year after heart transplantation, pulmonary artery pressures, pulmonary vascular resistance and cardiac index normalized in all patients regardless of the baseline hemodynamic profile. However, pulmonary arterial compliance remained lower in Cpc-PH patients (from 1.6±1.2 at baseline to 3.7±1.4 ml/mmHg at 1 year) than in Ipc-PH (from 1.2±2.0 to 4.4±2.3 ml/mmHg) and no-PH patients (from 3.7±2.0 to 4.5±1.8 ml/mmHg); (adjusted p = 0.03 Ipc-PH vs. Cpc-PH INT
- Published
- 2017
- Full Text
- View/download PDF
48. Obesidad: un desafío para las políticas públicas
- Author
-
Micaela Mussini and Karina L. Temporelli
- Subjects
fallas de mercado ,políticas públicas ,obesidad ,sobrepeso ,información asimétrica ,Nutrition. Foods and food supply ,TX341-641 ,Social sciences (General) ,H1-99 - Abstract
La obesidad es un problema médico que ha sido declarada epidemia mundial por la Organización Mundial de la Salud. El aumento de su prevalencia implica incrementos en los costos de los sistemas de salud, tanto en forma directa como indirecta, conjuntamente con un deterioro de la calidad de vida. Se vuelva un tema prioritario dentro de la agenda pública de los gobiernos. Las fallas de mercado presentes en el sector constituyen un argumento que justifica la intervención estatal. En función de ello, es que el objetivo del presente trabajo es analizar las fallas de mercado presentes en el sector y realizar una recopilación exhaustiva de las políticas públicas que han sido propuestas para el tratamiento y la prevención de la obesidad.
- Published
- 2013
49. Cardiopulmonary rehabilitation in patiens with heart failure and chronic pulmonary disease
- Author
-
Pier Luigi Temporelli
- Subjects
Chronic obstructive pulmonary disease ,chronic heart failure ,cardiopulmonary rehabilitation. ,Medicine - Abstract
The epidemiology of chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are well known. Each of these conditions has an important impact on quality of life and functional status and on healthcare consumption. Through shared risk factors and pathophysiological mechanisms CHF and COPD coexist more frequently than expected from the respective populations observed by the pulmonologist or cardiologist. This has important prognostic and therapeutic implications. Several registry-based studies and post-hoc analyses of large randomized controlled trials evaluating COPD as a comorbidity in CHF outpatients have highlighted the negative prognostic impact of the comorbidity in terms of constraint in use of recommended treatments. Among them, the cardiopulmonary rehabilitation may play a significant role. Even in these patients, in fact, a rehabilitative approach focused on physical training programs can positively impact functional autonomy, exercise tolerance and quality of life. Riassunto Attraverso i fattori di rischio condivisi e simili meccanismi fisiopatologici scompenso cardiaco cronico (SCC) e malattia ostruttiva cronica polmonare (BPCO) coesistono più frequentemente di quanto previsto dalle rispettive popolazioni osservate rispettivamente dallo pneumologo o dal cardiologo. Ciò ha importanti implicazioni prognostiche e terapeutiche. Diversi studi basati su registri e analisi post-hoc di ampi studi randomizzati controllati che hanno valutato la BPCO come comorbidità in pazienti con SCC hanno messo in evidenza l'impatto prognostico negativo della comorbilità in termini soprattutto di limitazioni all’utilizzo di trattamenti raccomandati. Tra questi un ruolo non trascurabile spetta alla riabilitazione. Anche in questi pazienti infatti un approccio riabilitativo incentrato su programmi di training fisico può impattare favorevolmente sulla autonomia funzionale, sulla tolleranza allo sforzo e sulla qualità della vita.
- Published
- 2016
- Full Text
- View/download PDF
50. La necessità di competenze multidisciplinari e il valore aggiunto della Cardiologia Riabilitativa nel paziente cardioperato
- Author
-
Pier Luigi Temporelli
- Subjects
Medicine - Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.